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ABSTRACT
In an effort to rationally design an apoptosis-sensitive MRI contrast agent, two novel
gadolinium complexes were designed, synthesized and evaluated as components of a
relaxometric probe. The first, AEDO3A will prove a useful building block for in the area of
the relaxometric probe design. AEDO3A•Gd has a relaxivity of 2.2 mM-1s-1 and 3.4 mM-1s-1
at 60Mhz and 500MHz, respectively. If AEDO3A•Gd is the “on” state and assuming
reasonable relaxivities for the “off” state, tissue contrast modeling of the smallest-detectable
relaxivity change suggests AEDO3A is suitable for incorporation into relaxometric probes.
1-(2-Aspartryl-aminoethyl)-4,7,10-tri(carboxymethyl)-cyclen (Asp-AEDO3A) is
evaluated as the second component of an apoptosis-sensitive relaxometric probe system. The
synthesis and characterization of the ligand and its Gd and Tb complexes is described.
Fluorescence lifetime data of the terbium complex indicate the presence of 0.6 water
molecules in the inner coordination sphere. The gadolinium complex has a relaxivity of
1.4mM-1s-1 and 1.7 mM-1s-1 at 60Mhz and 500MHz, respectively. Toxicity studies
demonstrated Xenopus embryos tolerated Asp-AEDO3A•Gd at magnetically useful
concentrations as predicted by tissue contrast modeling. X-ray crystallography data are
presented for both the ligand and gadolinium complex.
Unfortunately, no enzymatic processing of Asp-AEDO3A•Gd was observed under
any conditions. This phenomenon was attributed to heretofore-unknown coordination
chemistry for gadolinium elucidated from the X-ray crystal structure. This novel N-
carboxamido coordination, while problematic for the application of Asp-AEDO3A•Gd as a
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NOMENCLATURE
Apoptosis. An active and programmed process of cell elimination vital to
homeostasis.
B0. The constant (main) magnetic field of an MRI system. It is usually expressed in
units of Telsa (10,000 Gauss or about 20,000 times the magnetic field of the Earth).
CA. See Contrast Agent.
Contrast Agent. A substance that enhances (shortens) the relaxation time of water
molecules, making them appear ‘brighter’ in T1 or T2 weighted MR images. Abbreviated “CA”.
Inner Coordination Sphere. Used to describe any water molecules that are directly
coordinated to the metal ion inside a contrast agent.
Larmor Frequency. The Larmor frequency is the frequency of precession of the
nuclear magnetic moment (spins) and is proportional to the magnetic field strength as shown
in the Larmor equation, ω I = γ I B0 , where ωI is the Larmor frequency in Hertz, γI is the
gyromagnetic ratio of the nucleus and B0 is the magnetic field strength in Telsa.
MRI. Magnetic Resonance Imaging, a non-invasive technique using strong magnetic
fields and radiofrequency pulse to create images of internal anatomy.
µMRI. Micro-MRI is a specialized form of MRI with better spatial resolution (<500
µm). µMRI is typically performed in stronger field strengths than are typically employed in
clinical settings.
ix
NMR. Nuclear Magnetic Resonance, an analytical technique commonly employed in
chemistry.
Outer Coordination Sphere. Used to describe any water molecules that are not in the
inner- or second-coordination spheres.
Pm . The fraction of the solvent bound to the solvent. This is calculated by dividing the




q . The symbol used to indicate the number of water molecules inside the inner-
coordination sphere, i.e., directly coordinated to the metal ion in a CA.
Relaxation Time. The time it takes nuclear spins to return to their equilibrium state
after excitation by an RF pulse. Intensity in MR image is proportional to relaxation time.
Relaxivity. The ability of a contrast agent to shorten the relaxation time of nearby
water protons. The higher the relaxivity, the shorter the relaxation time.
Relaxometric Probe. A contrast agent that modulates, reversibly or irreversibly, its
relaxivity in response to a physiological stimulus.
Second Coordination Sphere. Used to describe any water molecules that are
coordinated to only the contrast agent ligand, not to the metal ion inside a contrast agent. For
example, a water molecule that is hydrogen bound to a polar group on the ligand.
Smart Contrast Agent. A contrast agent that can serve as a reporter of a physiological
or environmental stimulus. See Relaxometric Probe.
xτm. The average length of time a water molecule spends in the inner coordination
sphere.
τR. The rotational correlation time of a contrast agent. This is related to how fast the
contrast is physically tumbling in solution.
T 1. The longitudinal or spin-lattice relaxation time. The longitudinal relaxation time is
the time the longitudinal component of the net magnetization vector requires to return to the
ground state after excitation by a radiofequency pulse. This is representative of the energy loss
associated with high energy spins returning to their low energy state. The longitudinal axis is
equivalent to the axis of the external magnetic field (B0).
T2. The transverse or spin-spin relaxation time. The transverse relaxation time is the
time the magnitude of the transverse component of the net magnetization vector requires to
return to zero after excitation by a radiofequency pulse. This is representative of the loss of
proton spin phase coherence associated with the protons interacting with other protons. The
transverse plane is perpendicular to the axis of the external magnetic field (B0).
Voxel. A three-dimensional pixel in an MR image.
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C h a p t e r  1
INTRODUCTION
Magnetic Resonance Imaging (MRI) is a non-invasive technique using radio frequency
(RF) pulses and strong magnetic fields to create images of internal organs and structures.
Computer reconstruction of the data allows high-resolution arbitrary image planes to be
generated from a single image imaging procedure. MRI has found applications in almost all
areas of medicine, it is used to aid in the diagnosis of cancer, joint and musculoskeletal
disorders, and neurodegenerative and cardiovascular diseases.
Apoptosis is an active and programmed process of cell elimination vital to
homeostasis. It also has roles in development where the loss of cells serves many functions in
deletion of cells and structures [1]. The abnormal activation or repression of apoptosis is also
implicated in a wide variety of pathologies [2].
Magnetic Resonance Imaging
Magnetic resonance imaging is a valuable and versatile technique for visualizing
internal structures technique first described in 1978 [3]. MRI is an extension of nuclear
magnetic resonance spectroscopy used in chemistry. Certain atoms have an inherent magnetic
dipole moment that results from their electrical charge and spin. When placed in a strong,
steady magnetic field, these atoms begin to precess around the axis of the external magnetic
field, B0 (Figure 1a). The Larmor frequency, ωI, is the frequency of precession of the atom.
The orientation along the longitudinal axis, either with or against B0, determines the energy
level of the spin (Figure 1b). The difference in energy levels causes a net magnetization of the
2sample along the longitudinal axis because of a small excess of spins in the low energy states
vs. the high energy state, this net magnetization is best described as a vector. An RF pulse at
the Larmor frequency may be used to add energy to the spins, moving spins from the low-
energy state to a higher-energy state (Figure 1c). Consequently, the longitudinal component of
the net magnetization vector diminishes and eventually becomes negative (against B0) as more
RF energy is added to the spins. The relaxation time is the time it takes nuclear spins to return
to their equilibrium state. The relaxation time has two components, longitudinal and transverse
relaxation times, known as T1 and T2 respectively.
The intensity of a magnetic resonance (MR) image depends primarily on three factors
– the density of water protons, T1 and T2. The visual contrast is determined by the variation in
these parameters among tissues. MR images are usually weighed to highlight differences in
either T1 or T2, otherwise images would be fairly featureless because the density of water does
not vary significantly. A small magnetic gradient is added to B0, varying the strength of B0
Figure 1. Panel A. Procession of protons in an external magnetic field. Panel B. Proton spin
energy in a magnetic field. Panel C. Change in proton spin energy with increasing RF energy at
the Larmor frequency.
3across sample. Protons within the stronger portion of the magnetic gradient will exhibit a
higher Larmor frequency than protons located within the weaker segments. In this manner,
spatial information is represented by the Larmor frequency of the protons. The signals from
the water protons are detected by a sensitive receiver, and are analyzed by a computerized
system to create a visual representation for display on a computer screen. An example of an
MR image is presented (Figure 2).
Although satisfactory images are generated using T1 or T2 weighting, it is sometimes
desirable to add additional contrast to an MR image in order to highlight regions of interest.
This is accomplished by the use of small molecules called contrast agents (CA). CAs
dramatically shorten the T1 and T2 of water and their presence is easily detected in MRI images
Figure 2. Example of an MR image depicting an axial section through a human subject’s head.
The eyes and nose are clearly visible on the right hand side of the image.
4at levels as low as 0.1 mM. At the core of all CAs is a metal ion such as gadolinium, manganese
or iron. Among the ions, gadolinium has the greatest effect on T1 and hence is more
commonly used than the other ions. The unpaired electrons of gadolinium shorten the
relaxation time of nearby water protons, making voxels appear ‘brighter’ in T1-weighted
images. Through-space dipole-dipole interactions between nearby water protons and the
unpaired electrons cause this enhancement. Unfortunately, gadolinium ions also interfere with
calcium-dependant processes and are toxic. Consequently gadolinium is used in the form of a
chelate such as DOTA•Gd or DTPA•Gd (Figure 3). Both DOTA and DTPA make
gadolinium complexes that are exceedingly stable, ameliorating the toxicity while still allowing
the gadolinium ion to affect the T1 of water protons.
Apoptosis: Programmed Cell Death
It is well known cells in the body are constantly being replaced and replenished. In
fact, every year a mass of cells equal to the body weight is eliminated in order to make room
for these new cells [4]. The cells that are eliminated undergo a process of programmed cell
death called apoptosis. This process was first identified and coined in 1972 [5]. Apoptosis
Figure 3. Examples of two contrast agents. DOTA and DTPA are polyamino-carboxylate


























5literally means “falling leaves” in Greek, relating apoptosis in an organism to the annual
shedding of leaves by deciduous tree in the autumn.
Apoptosis is different from necrotic cell death [6]. Although the difference between
the two may not always be clear, apoptosis is generally characterized by distinct morphological
characteristic such as cytoplasmic shrinkage, chromatin condensation, membrane blebbing and
fragmentation into vesicles. There are also extensive biochemical changes that accompany the
visible indicators of apoptosis. The composition of the cell membrane changes so that cells
undergoing apoptosis are recognized by macrophages that will eventually consume the
apoptotic cell. Chromosomal DNA is fragmented and a specific family of intracellular
proteases becomes activate. These proteases are collectively known as caspases and disable
cellular repair enzymes while activating other downstream proteases to quickly dissemble and
package the apoptotic cell for efficient recycling.
Apoptosis can be triggered by many stimuli such as lack of growth factors, hormonal
influences or mild toxic insults; active T-cells can also induce apoptosis in other cells.
Apoptosis is important to homeostasis and its inappropriate activation or suppression can lead
to many different pathologies. Abnormal apoptosis activity has been implicated in immune
system disorders [7, 8], carcinogenesis and treatment [9-11], viral infections [12], diabetes [13],
stroke [14-16], traumatic brain injury [17, 18], aging [19, 20] and even neurodegenerative
diseases [21].
Common assays for apoptosis detection typically rely on one of three phenomenon,
(1) activation of proteases, (2) DNA fragmentation or (3) changes in the plasma membrane.
The protease whose presence is typically detected in the first type of assay is caspase. Caspase
6are a family of proteases which were first identified in C. elegans as necessary for programmed
cell [22] and their activation is considered the defining biochemical event of apoptosis [23].  In
the second type of assay, DNA fragmentation is detected using a variety of enzymatic or
chromatographic methods. The pattern of DNA fragmentation that occurs during apoptosis is
distinctive, fragments are multiples of 180 base pairs – the distance between the histone
nucleosome cores on DNA.   In the final type of assay, changes in the asymmetry or
permeability of the plasma membrane are used as markers for apoptosis. For instance, during
apoptosis phosphatidylserine translocates from the cytoplasmic side of the plasma membrane
to the extracellular side. This translocatation is detected using Annexin V, which binds
extracellular phosphatidylserine. All of these techniques rely on colormetric, fluorogenic or
chromatographic detection and hence are limited in their application in vivo. This project seeks
to develop a novel MRI-based assay for apoptosis as the first step in an in vivo diagnostic.
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C h a p t e r  2
RELAXOMETRIC PROBES
Relaxometric probes serve as reporters of physiological function by altering their
relaxivity in response to a variety of stimuli, such as pH [24, 25], O2 saturation [26, 27],
presence of specific proteins [28, 29], temperature [30, 31], metal ion concentration [32, 33] or
enzyme activity [34-37]. These relaxometric probes modulate their relaxivity through a myriad
of mechanisms. In order to best appreciate the different mechanisms involved in relaxometric
probes, the theoretical basis of relaxivity will need to be explored in some detail.
Relaxivity
In a T1-weighted image, the signal intensity of the voxel will be inversely proportional
to the T1 of the water protons contained within that voxel.  The observed relaxation time is the
sum of the intrinsic relaxation time of the solvent and the contribution from the CA
(Equation 1). The superscripts “OBS,” “SOL,” and “CA” are used to respectively indicate the











CA  is modeled as the sum of three independent components (Equation 2). The
superscripts “IS”, “SS” and “OS” are used to respectively indicate the inner-, second- and
outer-sphere contributions to T1
CA . The relaxation time of water molecules in the inner-
coordination sphere (i.e., directly coordinated to the paramagnetic metal ion) is expressed as
8T1
IS . The relaxation time of nearby water molecules is also affected and their contribution to
T1
CA is expressed in two separate terms, T1















The inner-sphere contribution to T1
CA  is given in Equation 3, where q is the number
of water molecules in the inner-coordination sphere, Pm is the fraction of water molecules
inside the inner-coordination sphere, τm is the average length of time a single water molecule
resides within the inner-sphere coordination sphere and T1m is the relaxation enhancement







Solomon-Bloembergen-Morgan theory [38, 39] provides a foundation to understand
the basis of T1m (Equations 4-8). The two components of T1m term (Equation 4) are dipole-































































































quite small in most CAs, consequently the contribution of T1
SC  to T1m may be safely ignored
and will not be considered further.
Thus T1m is largely determined by the magnitude of the dipole-dipole interactions given
in Equation 6. γH is the proton gyromagnetic ratio, g is the electronic g factor,  µB is the Bohr
magneton, S is the number of unpaired electron in the paramagnetic metal ion, r is the distance
between the water protons and the unpaired electrons of paramagnetic metal ion, ωH/ωs are
the Larmor frequencies of protons and electrons respectively, and τ1c, is the local correlation
time of the contrast agent. The electronic contributions (the “7” term inside the square
brackets) may be conveniently ignored because at field strengths used in MRI, ωs
2τ c2
2  >> 1,
reducing the electronic contributions to an insignificant amount. The nuclear contribution (the
“3” term inside the square brackets) is determined by ωH
2 , the proton Larmor frequency, and
τ1c, the local correlation time. The relaxation enhancement efficiency of the CA depends on
how closely matched the proton frequency (i.e., the Larmor frequency, ωH) is to the correlation
10
frequency of the contrast agent (1/τc1). The nuclear contributions to relaxation are maximized
when 1/τ1c approaches the Larmor frequency of the protons.
The local correlation time (τ1c) has three components, T1e – the electronic relaxation
time of the unpaired electrons, τm – the water residency lifetime, and τR – the rotational
correlation lifetime (Equation 7). The high-field strengths used in MRI again simplify matters,
T1e is long enough to reasonably ignore the contributions from the 1/ Tc1 term. τm is the same
term from Equation 3. τR is rotational correlation time and is related to physical tumbling
time of the CA in solution.
Second- and Outer-sphere Relaxivity
Water molecules not directly coordinated to the metal ion also experience relaxation
enhancement in the presence of the CA. These water molecules may be organized into a
second- and outer-coordination sphere (Figure 4). Solomon-Bloembergen-Morgan theory
may also be applied second-sphere water molecules, thus T1
SS  may be modeled from
Figure 4. Three coordination spheres, the inner-sphere molecules are directly bound to the
metal, the second sphere consists of water molecules coordinated to other parts of the CA



































Equations 3 and 6. The deviating terms are noted with a prime, e.g., q', r' and τm', to
differentiate them from the unvarying terms, wH and S. Outer-sphere relaxation enhancement
may be modeled using theories developed by Hwang and Freeman [40, 41]. T1
OS  is estimated
using Equations 9-12. Essentially T1
OS  is determined by T1e (vide supra), a – the minimum
distance of approach between the metal complex and the outer-sphere water molecules, and D
– the sum of the diffusion constants of outer-sphere water molecules and the CA. The
remaining terms are NA - Avogadro’s Number and M – concentration of CA.
1
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i = H,s [11]






i ≡ −1, j = H,s [12]
Separating the inner-, second- and outer-sphere components of T1
CA  is problematic.
An approach often used to approximate T1
IS  of a CA is to simply deduct the T1
CA  of a second,
related CA that has q= 0. In the case of the second CA, T1
IS  is zero (because q = 0) and the
observed relaxation enhancement is attributed solely to T1
SS  and T1
OS . This provides a
reasonable estimate of T1
SS  and T1
OS  for the first CA because these parameters are not
12
expected differ significantly among structurally related CAs. However there are notable
exceptions to this assumption and this approach must be carefully applied (Figure 5).
Presently, there is no satisfactory experimental method to partition the second- and  outer-
sphere components of T1
CA
Relaxometric Probes
Relaxometric probes serve as reporters of specific environmental events or conditions
by modulating their degree of the relaxation enhancement. This modulation occurs because
the environmental event or condition alters one or more of the parameters in Equations 2-12.
In order to better understand the potential of the different parameters to affect T1
CA ,
Equations 2-12 are condensed and presented into Equation 13. Two reasonable assumptions
Figure 5. Neither DOTP•Gd nor DOTPME•Gd have any water molecules in the inner-
coordination sphere, yet their respective relaxivities are 5.0 mM-1s-1 and 2.0 mM-1s-1. This
disparity is presumably caused by the phosphonate arms of DOTP•Gd that are capable of







































are made in simplifying the equations, [1] 
1
T1











≈ 0  for water proton-
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+ ′ τ m
Second −Sphere Contribution6 7 4 4 4 4 4 8 4 4 4 4 4 
+ kOS
1
S S +1( )M 3 j ω H( ) + 7 j ωs( )[ ]
Outer−Sphere Contribution6 7 4 4 4 4 4 8 4 4 4 4 4 
[13]
The overriding criterion for the utility of a relaxometric probe is the change in T1
CA ,
therefore parameters that are unfixed are the most relevant. These parameters are q, q', r, r', τc1,
τc1', τm, τm', S and M. The remaining parameters are either physical constants or determined by
B0.
M-based Relaxometric Probes
Recalling that contrast is proportional to 
1
T1
, it is desirable to increase M in response
to an environmental trigger because 
1
T1
CA ∝M . Modulation of M is accomplished in vivo by
designing a CA with a specific affinity for the tissue of interest. In this way, the CA may be
administered systemically but accumulates in specific tissues, increasing the local concentration
and hence the contrast. Many CAs have utilized antibodies [42-44] and receptor ligands [45-49]
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for this purpose. This method is perhaps the most straightforward, both conceptually and
practically, although there some difficulties involved with overcoming the low concentration of
antigens and receptors.
q-based Relaxometric Probes




Modulating q in a relaxometric probe requires altering the coordination environment of the
complex. This has been accomplished via two methods. The first method uses coordinating
groups that bind the paramagnetic metal ion in the CA, serving to displace water molecules
from the inner coordination sphere. These coordinating groups are only loosely bound and
will preferentially bind other metal ions (Figure 6). This mechanism has been used in Ca2+ and
Zn2+ sensitive relaxometric probes [32, 33]. The second method for increasing q is the use of a
group that is not coordinated to the paramagnetic metal ion, but still serves to exclude water
Figure 6. The mechanism for relaxation enhancement in a Ca2+ sensitive contrast agent [32].
In the absence of calcium ions, a loosely coordinated carboxylate fills the coordination
sphere of the gadolinium ion, preventing water molecules from approaching. The addition of


































molecules by virtue of steric bulk. Two β-galactosidase-sensitive CAs function through this
mechanism [35, 36] (Figure 7A), although data cannot exclude an alternate mechanism
(Figure 7b).
τc1-based Relaxometric Probes (or τR-based Relaxometric Probes)









































































Figure 7. Panel A. The action of β-galactosidase removes the galactosyl residue from the
contrast agent, thus allowing water molecules to enter the inner coordination sphere. Panel B.
Bidentate ligands, such as CO3
2- or PO4
3- present in the solvent may displace the galactosyl
moiety and coordinate to the gadolinium. This fills the inner-coordination sphere and prevents
water molecules from entering. Enzymatic processing reveals a hydroxyl group, an efficient



















 if T1m >> τm . The nuclear dipole-dipole interactions are
maximized when τ c1 =
1
ωH
. τc1 has three components, T1e, τm, and τR (Equation 7), but as
previously pointed out, T1e may be sensibly ignored in most µMRI regimes. Accordingly τc1 is
approximately equal to the smallest of τR and τm.
It is generally true in CAs that τR << τm  and τR <
1
ωH
, consequently the short τR is a
limiting factor in 
1
T1
CA  and lengthening τR is desirable. This has been accomplished dynamically
in relaxometric probes through a myriad of methods (Figure 8). In one example, an enzyme
catalyzed the oligomerization of a relaxometric probe, lengthening τR wherever the enzyme was
active [37]. In another, the relaxometric probe is processed enzymatically into an effective
ligand for a ubiquitous protein, human serum albumin [34]. Different specific receptor-ligand
interactions with DNA-transcription factors [29], carbonic anhydrase [28] or oxyhemoglobin
[27] are utilized in other relaxometric probes. In the final example, the relaxometric probe
undergoes pH-dependant changes to its secondary-structure, altering its τR [24].
Although τm –based relaxometric probes do exist, the fundamental explanation for
their responsiveness in 
1
T1
CA  is not through modulation of τc1 (vide infra). They will be described
in a separate section below.
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Figure 8. Several representations of τR-based relaxometric probes. Panel A. Enzyme-
catalyzed oligomerization increases molecular weight [37]. Panel B. Thrombin-
activatable fibrinolysis inhibitor (TAFI) removes polar amino acids, increasing the
probe’s affinity for human serum albumin [34]. Panel C. A pseudo-inhibitor (a
sulfonamide-derivatized probe) of carbonic anhydrase (CA) forms a non-covalent
adduct with the enzyme [28]. Panel D. A peptide-conjugated probe is recognized and
bound by Gal80, a yeast DNA transcription factor [29]. Panel E. A pH-sensitive
relaxometric probes undergoes extensive remodeling of the secondary structure in
response to protonation and deprotonation of the lysine side chains. For example,
acidifying the pH would increase the rigidity of the structure as the protonated amines
began repelling one another [24].



























































































In this case 
1
T1
CA  is instead limited by τm. This limitation is not a function of the local
correlation time of the complex, τc1, rather it is purely a function of the number of water
molecules cycling through the inner-coordination sphere. The magnitude of 
1
T1
CA  is limited by
the longest term between T1m and τm in Equation 3. While it is desirable to have τm << T1m so
water exchange rates are never a limiting factor, in practice τm is extremely difficult control. In
any case, the limiting effects of slow water exchange in complexes with very long rotational
correlation times has been utilized to make a temperature-sensitive relaxometric probe [31].
S-based Relaxometric Probes
It is desirable to increase S in response to an environmental trigger because 
1
T1
CA ∝ S  if
T1m >> τm  . A relaxometric probe which incorporates this mechanisn is a pO2-sensitive
relaxometric probe incorporating a redox-sensitive Mn2+/3+ ion [26]. It should be noted that in
this specific case, the change in S is not the primary mechanism for the relaxation
enhancement, however this serves to illustrate the potential applications of an S-based
relaxometric probe in a redox sensitive contrast agent.
19
Other mechanisms
A relaxometric probe that functions by modulating r has not reported. It is
theoretically possible to modulate r, the design of such a ligand would be difficult. However
even a small change in r, for example 0.2 Å, results in a 30% change in relaxivity because of the
r6-dependence of T1m.
Deliberate modulation of the second- or outer-sphere contributions in a relaxometric
probe have only been reported in T2-contrast agents [50, 51]. There are no reports of a T1-
contrast agent purposely designed to modulate the second and outer spheres.
Finally, there is also an emerging class of CAs have nothing to do with relaxation time.
These CAs utilize chemical-exchange saturation transfer (CEST) pulses to reduce the contrast
wherever they are present. Instead of enhancing relaxation rates, these contrast agents serve as
‘antennas’ for saturating RF pulses that ‘erase’ nearby water protons for a short time from
subsequent MR images, resulting in areas that appear darker than the surrounding tissue in MR
images. For a detailed description of the mechanism, the reader is referred to the published
literature on this subject [52, 53]. Smart CEST agents have been designed that report on
temperature and lactate concentration [54, 55].
Practical Aspects
It would be useful to apply real numbers to these equations to obtain an understanding
of the contributions of τm and τR in a typical CA. For this purpose we’ll work at a typical
magnetic field employed µMRI (B0 = 11.7 Tesla), at this field ωH  is 500 Mhz. Starting with
some prototypical values, τR = 50 ps, τm = 250 ns, q =1 and r = 3.1 Å , we have a CA with a
20
relaxivity of 4.0 mM-1s-1. This CA has τc1= 50 ps, far shorter than the optimal value of 2 ns
(ωH
−1, 500 MHz-1).
It is valuable to consider how changes in τm and τR affect the relaxivity. Since τR <<
ωH
−1, the relaxivity is not limited by slow water exchange. Consequently, shortening τm to
125ns only increases the relaxivity to 4.1 mM-1s-1, a minimal improvement of .1 mM-1s-1.
Lengthening τR to 100 ps has a more pronounced effect; the relaxivity increases to 7.6 mM
-1s-1.
In general for small molecule contrast agents, τR is the primary determinate of relaxivity and τm
has very little effect. Only a relatively small number of polyamide derivatives of DOTA and
DTPA have τm’s long enough to adversely affect the relaxivity of small molecule contrast
agents with short τR’s.
Linking this CA to a large protein such as albumin will typically lengthen τR to ~2000.
Under these conditions, τc1 is 1.9 ns – very close to being optimal – and the “theoretical”
relaxivity, T1m, is 84 mM
-1s-1. Unfortunately if τm remains unchanged at 250 ns, the actual
relaxivity is only 40 mM-1s-1 because it is now limited by the long water exchange time.
Shortening τm to 50 ns ameliorates this limitation and increases the relaxivity to 68 mM
-1s-1.
Designing an apoptosis-sensitive relaxometric probe
A relaxometric probe will be synthesized and evaluated in an effort to detect apoptosis
in vivo. A q-based relaxometric probe was chosen because of extensive experience with the
design and synthesis of such molecules [32, 35, 36]. In a scheme analogous to prior
relaxometric probes synthesized in this lab, a suitable effector moiety will be attached to
DO3A. The effector moiety would serve to exclude water molecules from inner-coordination
sphere and lower the relaxivity. Theoretically, the removal of the effector moiety is
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accomplished by the specific action of an enzyme, restoring the relaxivity of the contrast agent
and producing a detectable signal in the MR image.
The first step was choosing the enzymatic target. The criteria for the enzyme are
straightforward, (1) the enzyme must be capable of hydrolyzing a bond and (2) it should
specific to apoptosis. Caspases were immediately identified as the preferred enzymatic target
because their activation is the defining biochemical event associated with apoptosis.
Furthermore, caspases have many aspects that make them an ideal enzyme to target. They are
activated fairly early in the apoptotic cell [56], allowing a longer period for the enzymatic
processing to occur which can be quite prolonged in relaxometric probes. Caspases also have a
relatively short 4 amino-acid consensus sequence and are exo-peptidases rather than endo-
peptidases [57] facilitating the design of the linker between the CA and effector moiety. Finally,
caspases are rather promiscuous enzymes, they can efficiently process a diversity of single
amino-acid substrates including L-Asp, L-Arg, L-Glu and even D-Asp [58]. This also served as
a preliminary indication the enzyme would recognize and process the relaxometric probe being
designed.
Initially the entire consensus sequence for caspase-3 was considered for incorporation
into the relaxometric probe, however when it was discovered that a single aspartate is also an
efficient substrate, the tetra-peptide was dropped in favor of the single amino acid as the
effector moiety. The single aspartate is sufficient bulky to block water molecules from entering
the inner-coordination sphere. Furthermore, the carboxylate side chain and N-terminal amine
might coordinate to the metal ion, saturating the inner coordination sphere instead just
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blocking water molecules. When the bond between the amino acid and the CA is cleaved,
these inhibitory effects will be removed, restoring the relaxivity.
After the molecular target was chosen, a survey of known CAs was conducted in order
to find one that would serve as suitable building block. Although there are many examples of
CAs linked to peptides or amino acids, this linkage is usually either (1) accomplished by
recruiting a carboxyl group on the ligand to couple to an amine on the peptide [59] or (2)
through a amine group on the ligand located distal to the apical coordination site [60, 61]. A
promising candidate was the ligand 1-(2-aminoethyl)-4,7,10-tri(carboxymethyl)-cyclen
(AEDO3A).  Figure 9 illustrates how AEDO3A would be incorporated into a relaxometric
probe.
AEDO3A was chosen because it contains a pendant amine, allowing the attachment of
the effector moiety – the single aspartate – through an amide bond. This amide bond could be


































Figure 9. Proposal for an apoptosis-sensitive relaxometric probe. The Asp-AEDO3A, the “Off”
state, would be processed by caspase to liberate AEDO3A, the “On” state.
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pendant amine are likely to place it adjacent to the apical coordination site, maximizing the
likelihood that the effector moiety will be able to efficiently displace water molecules from the
inner-coordination sphere. However, the application of AEDO3A as a CA ligand has not been
reported, therefore the synthesis of the gadolinium and terbium chelates had to be undertaken
to before AEDO3A could confidently be included as a component of the apoptosis-sensitive
relaxometric probe.
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C h a p t e r  3
ESTIMATION AND REDUCTION OF ERRORS IN RELAXIVITY
The ordinary linear fit of 1/T1 vs. concentration has traditionally been used to estimate
the relaxivity of CAs. However, the ordinary linear fit is not well suited to handling 1/Ti data,
errors are neither weighed nor propagated properly. Consequently, errors in the T1 data do not
‘average’ out and its use should be avoided. Two novel methods of estimating relaxivity are
evaluated as alternatives. The first method is a weighted least-squares fit directly to the T1 data.
The second method is a distribution-free (or non-parametric) method. A Monte Carlo
simulation used to evaluate the accuracy and precision of each method. Both the direct fit and
distribution-free methods proved more precise than the ordinary linear fit. These novel
methods will prove in reducing uncertainty in relaxivity estimate.
Introduction
The relaxivity change that occurs during the relevant physiological event is a major
criterion for the utility of any relaxometric probe. Tissue contrast modeling suggests that
changes as small as 0.9 mM-1s-1 in the relaxivity of CAs may reasonably be detectable in T1-
weighted images [63]. Thus, the precision of the estimates is an important concern when
evaluating the utility of relaxometric probes. Unfortunately relaxivity estimates can be elusive;
for example the relaxivity of a well-known CA, DOTA, has been independently reported to be
anywhere between 3.5 mM-1s-1 [64] and 4.8 mM-1s-1 [65] – a range of 1.3 mM-1s-1 which is larger
than the smallest-detectable relaxivity change in a relaxometric probe system. On the surface,
this uncertainty in the estimation of relaxivity appears to make in vitro evaluation of
relaxometric probes untenable. Fortunately a substantial portion of this variability is accounted
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for by differences in experimental conditions such as temperature, buffer or field strength.
When measuring relaxivity changes in relaxometric probes, these factors are kept constant and
a comparison between the different relaxivities may more confidently be made.
In order to estimate relaxivity, relaxation times of solutions with differing
concentrations of CA are measured. Relaxivity is defined as the concentration dependence of
1/T1. The simple linear relationship between 1/T1 and concentration appears to make the
estimation of r1 a trivial calculation of the least-squares ‘best’ fit line. This is not the case. The
ordinary linear least-squares fit does not properly propagate nor weigh the errors in the data. A
simple non-technical explanation of these points follows. For a more thorough discussion of
these points, the reader is directed to the published literature on these topics [66].
Formal error propagation is necessary when taking the reciprocal distorts errors in T1
data (i.e., it is a nonlinear transformation). Taking the reciprocal of T1 increases errors in one
direction and decreases them in the other. This becomes readily apparent in an extreme
example such as 1 s ± 0.5 s, the range of possible values is 0.5 s - 1.5 s. Taking the reciprocal
results in 1s-1 with a possible range of 2 s-1 - 0.66 s-1. The error after the reciprocal
transformation is clearly no longer Gaussian, this violates a basic assumption of the linear
least-squares fit. Proper weighing of errors is also important. Most experimental techniques to
estimate T1 give constant relative errors (i.e., ± 3%) rather than constant absolute error (i.e., ±
5 ms). After the reciprocal transformation, this inadvertently results in points with lower T1
values (e.g., higher concentrations) being weighed more heavily when estimating the r1.
This mishandling of errors is a minor, but significant, violation of the assumptions
made in a simple linear fit. Consequently, the simple linear least-squares fit only provides a
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reasonable estimate of r1 not the best estimate.  Although it is certainly possible to derive the
appropriate corrections to enable the use of a linear fit, it is more expeditious to use a simplex
algorithm to find an r1 that most closely matches the observed T1 data. Furthermore, a non-
parametric method to estimate r1 is proposed and evaluated.
Methods
Linear fit
The linear fit is the traditional method of calculating relaxivities. It is simply the slope
of the best-fit line of 1/T1,i versus [Mi]. This is calculated using the Linest() function in
Microsoft Excel (Redmond, WA). The Y-intercept was not fixed and calculated by the
algorithm.
Direct fit
The direct fit uses a simplex algorithm that iteratively calculates an r1 that minimizes
the weighted sum-of-squared deviations in T1 (Equation 14).






The weight (ω) is 1/ ˆ T 1,i
2 and corrects for the difference in the magnitude of the
variation at different T1’s. The value ˆ T 1,i  is calculated (Equation 15) using the empirically
determined T1 of the buffer system as ′ T 01.













This model was constructed using Excel and solved using a simplex algorithm
accessed via the Solver plug-in. A sample spreadsheet of this model is included in the
Appendix.
Distribution-free method
The distribution-free method calculates r1,ij (Equation 16) for all possible pairs of T1’s
in the data set and returns the median (not the average) value. There are (N)*(N-1)/2 unique
pairs in a data set consisting of N samples. For example, in a data set consisting of three CA
concentrations {(T1,a,[Ma]), (T1,b,[Mb]), (T1,c,[Mc])} and one blank measurement {(T01,d,[0.0])},
there are six unique pairs of data. (i.e., A-B, A-C, A-D, B-C, B-D, C-D). The relaxivity for each
unique pair is calculated and median value is considered the relaxivity of the CA. A sample







Mi[ ] − M j[ ]
[16]
Figure 10. Distribution of the errors factors used in the Monte Carlo simulations. N=25,000
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Monte Carlo Simulations
The Monte Carlo simulation was performed using Excel. Theoretical T1 values were
calculated from Equation 3 (r1 = 3.1 mM
-1s-1, T01 = 2.0 s) at several concentrations of CA. An
‘observed’ T1 was calculated by introducing stochastic error into the theoretical T1. The error
was randomly generated for each individual data point and was normally distributed (Figure
10) with a fixed mean and standard deviation. The relaxivities were then estimated using the
linear fit, direct fit and the distribution-free methods.
The simulations were performed under a variety of error conditions (SD= 2.5%, 5%,
10%) and data set sizes (N=2-7).
Results
The results of simulated relaxivity estimates were analyzed to ascertain their accuracy
and precision (Figure 11). For example, if one uses 6 data points and assumes 5% error in the
underlying T1 data, then the error in the relaxivity estimate will be approximately ± 4.6% using
the direct fit or ± 9.5% using the linear fit. Although the difference in accuracies (data not
Figure 11. Distribution of relaxivity estimates produced by the direct fit (solid line),
distribution-free method (short dashes) and the ordinary linear fit (long dashes) for data sets
consisting of 3, 6 or 12 concentrations (Panels A, B  and C, respectively). These curves
assume 5% error in the underlying T1 data.
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shown) between the methods is statistically significant because of the large sample sizes used in
the simulations, the magnitude of the differences, less than 0.5%, is not relevant to most
discussions of CA relaxivity. Hence when judged solely on the basis of accuracy, all methods
performed equally well.
However, the precision of relaxivity estimates differed by a noteworthy amount. As
expected, the direct fit returned the most precise estimates while the linear fit performed the
worst. Indeed, using linear fit is not much better than simply estimating relaxivity solely from
most concentrated sample – regardless of the actual number of concentrations used in the fit.
This is expected from the incorrect weighing of the individual data points and is borne out in
the Monte Carlo simulations.
The direct fit estimates were the most precise of the three methods evaluated. Directly
comparing T1 and ˆ T 1, as opposed to 1/T1 and 1/ ˆ T 1 in the linear fit, avoids the confounding
reciprocal transformation required in the linear least-squares estimation. Furthermore, the
variation at each [Mi] is weighed for more accurate treatment of error. Consequently, the
precision of the direct fit method increases with increasing number of data points used. As one
would expect, this decrease in variation is roughly proportional to the square root of the
number of data points used.
In contrast to the direct fit method that assumes a normal distribution of error and a
constant proportional variance, the distribution free method uses a much simpler assumption
– positive errors are as likely as negative errors. The detriment to this method is that it
produces a weaker conclusion (more uncertainty) because it relies upon weaker assumptions.
In the event that the classical assumptions are true, a parametric method such as the direct fit
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will always produce results that are more
precise. However, a non-parametric analysis
such as the distribution free method will
provide better estimates, in general, than a
poorly chosen parametric analysis, as is the
case with estimating relaxivity with the
linear fit.
Goodness of fit is best assessed
visually (Figure 12). The reciprocal plot of
T1 can be misleading because it visually
distorts the magnitude of the error in all the
data points and gives misleading
information to the viewer about the
goodness of fit. Neither is the direct plot
ideal either for the visual inspection of the
goodness of fit. A plot of the weighted
residuals [1− ˆ T 1,i T1,i( ) ] is the most useful
visual indicator of goodness of fit. It is vital
to consider that the data in Fig. (2) contains
a reasonable amount of error (5%) and the
Linear Fit appears optimal, yet the error in
the resulting relaxivity estimate is 8.4%. This
N Direct Fit Linear Fit Distribution Free
2.5% Error
2 1.71% 2.55% 2.55%
3 1.64% 2.61% 1.94%
4 1.42% 2.68% 1.84%
5 1.32% 2.48% 1.84%
6 1.10% 2.32% 1.68%
8 3.77% 8.36% 6.04%
10 0.77% 1.91% 1.33%
12 0.72% 1.75% 1.19%
5% Error
2 3.65% 4.94% 4.94%
3 3.42% 5.45% 4.06%
4 2.87% 5.10% 3.52%
5 2.52% 4.90% 3.58%
6 2.29% 4.77% 3.29%
8 1.89% 4.25% 2.98%
10 1.62% 3.92% 2.73%
12 1.40% 3.46% 2.29%
10% Error
2 7.39% 10.45% 10.45%
3 6.52% 10.65% 7.84%
4 5.87% 11.06% 7.58%
5 4.90% 10.35% 7.23%
6 4.39% 9.26% 6.39%
8 3.77% 8.36% 6.04%
10 3.25% 8.22% 5.57%
12 2.72% 7.30% 4.75%
Table 1. The standard deviations of the
various simulated relaxivity estimates are
presented. Each line in the table presents
standard deviations (expressed as a
percentage) of relaxivity estimates generated
by the three methods using 2000 sets of T1
data with the stated error and number of
data points (not including the blank). These
values are useful for approximating the error
in individual relaxivity estimates because
95% of the time the ‘true’ relaxivity will be
± 2 standard deviations away.
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highlights the uncertainty present in relaxivity estimates regardless of the visual appearance of
the plotted data.
Discussion
 The errors associated with estimating relaxivities are numerous and the statistical
model used should reduce these errors. The ubiquity of Excel and other spreadsheets make the
calculation of the direct fit and distribution free methods only slightly more laborious than the
Figure 12. Panels 2a and 2b present reciprocal and direct plots of the following T1 data ([Mi],
T1,i) = [(0 mM, 1.93 s), (0.63 mM. 405 ms), (1.25 mM, 246 ms), (2.5 mM, 122 ms), (5 mM, 59.1
ms), (10 mM, 29.6 ms)] with superimposed Direct and Linear Fits using T01 of 1.93 s. This T1
data was generated from a ‘true’ r1 of 3.1 mM
-1s-1 with a random error (εi) = (0.932, 0.946,
1.000, 1.078, 0.988, 0.969). Panel a. The Linear Fit (dashed line) appears to fit the data quite
well, while the Direct Fit (solid line) seems to miss the 5mM and 10mM points. Panel b. The
direct plot is not better for judging the goodness-of-fit. The difference between the two fits
appears minor. Panel c. The plot of the weighted residuals is the most useful visual indicator of
goodness of fit. The residuals from the direct fit appear centered on the X-axis while residuals
from the linear fit lie mostly above the X-axis. Although visually the differences appear minor,
the calculated relaxivities from the Linear and Direct Fits are 3.36 mM-1s-1 and 3.12 mM-1s-1
respectively. For comparisons sake, the Distribution Free method estimated a relaxivity of 3.31
mM-1s-1.
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linear fit. The use of the linear fit should be avoided and either the direct fit or distribution free
method substituted in its place. The direct method provides the most precise estimates of
relaxivity, however like all parametric methods it is sensitive to outliers. Because visually
detecting outliers or assessing the goodness of fit is difficult, unless residuals plots are
inspected the distribution free method should be employed. This method handles errors,
including outliers, in a robust manner yet still produces more precise estimates than the linear
fit. The uncertainty reported in relaxivity should reflect the number of concentrations used in
the determination and allow statistically significant conclusions to be made.
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C h a p t e r  4
AEDO3A – A USEFUL BUILDING BLOCK FOR A RELAXOMETRIC PROBE
1-(2-Aminoethyl)-4,7,10-tri(carboxymethyl)-cyclen (AEDO3A) is evaluated as a
component of a relaxometric probe system. The synthesis and characterization of the ligand
and its Gd and Tb complexes is described. The gadolinium complex has relaxivities of
2.2mM-1s-1 and 2.4 mM-1s-1 at 60Mhz and 500MHz respectively. Fluorescence lifetime data of
the terbium complex indicate the presence of 0.9 water molecules in the inner coordination
sphere. X-ray crystallography data are presented for both the ligand and gadolinium complex.
Assuming reasonable relaxivities for the “off” state, tissue contrast modeling of the smallest-
detectable relaxivity change suggests AEDO3A is suitable for incorporation into relaxometric
probe the desired relaxometric probe.
Synthesis
Attempts to synthesize this agent using the literature procedure produced
unsatisfactory yields in this laboratory. Consequently, a new synthetic route (Scheme 1) was
developed that required neither silica-gel chromatography nor HPLC to purify intermediates.
AEDO3A was synthesized in four steps starting from 2-bromoethylamine. The 2-
bromoethylamine was acylated with BOC-anhydride to yield the BOC-protected derivative (1)
that was then reacted with a 5-fold excess of cyclen to promote monoalkyation. Compound 2
was exhaustively alkylated with t-butyl bromoacetate to yield the fully protected ligand 3.
Deprotection using TFA yielded the final ligand 4. The final complexes, 5a and 5b, were
formed from the correct lanthanide chlorides under slightly acidic conditions, pH 6-7. The
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final complexes were purified by precipitation followed by column chromatography (Biorad
Chelex) and dialysis to remove any trace heavy metals.
All reagents and solvents were purchased from Aldrich, Fluka, or Strem (cyclen) and
were used without further purification. Ion exchange resins purchased from Bio-Rad.
N-Boc-2-aminoe thy l bromide  (1) .  A 1N solution of sodium hydroxide (160 ml) was
added dropwise over 15 minutes to a vigorously stirring biphasic system of bromoethylamine
hydrobromide (17.85 g, 87.1 mmol) in water (100 ml) and di-t-butyl pyrocarbonate (9.5 g, 43.5
mmol) in dichloromethane (100 ml). After 2 hours, the layers were separated and the organic
layer was washed with 1H HCl (25 ml) twice and a saturated sodium chloride (25 ml) once.
The organic layer was then dried over sodium sulfate and concentrated in vacuo to a colorless









































Scheme 1: Synthetic Scheme for AEDO3A. a) BOC-anhydride, NaOH, DCM/H2O, yield 70%; b)
cyclen, MePh, yield 56%; c) t-Butyl bromoacetate, Na2CO3, yield 85%; d) TFA,
Triisopropylsilane, yield 45%; e) MCl3, LiOH, pH 6-7, H2O, yield 50%
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white solid that crystallized was filtered and washed with cold hexanes. The combined filtrates
were again placed at –80°C for 1 hour to precipitate a second batch of crystals weighing 4.9
grams. Total yield, 6.8 grams (30.3 mmol or 70% yield). 13C NMR (CDCl3, 300 MHz) δ 155.6,
79.8, 42.3, 32.8, 28.3. 1H NMR (CDCl3, 300 MHz) 5.03 (s, 1H), 3.53 (t, 2H), 3.46 (t, 2H), 1.46
(s, 9H). HR-CI+GC, m/z 224.0286 (M+H) theoretical 224.0286.
(N-Boc-2-aminoe thy l) -cyc len  (2) .  A solution of 1 (10.3 g, 45 mmol) and cyclen (30.96
g, 180 mmol) in toluene (400 ml) was stirred at 70°C overnight. The following day, the product
was extracted from the reaction mixture using water (100 ml, 4x). The combined aqueous
layers were washed with toluene (50 ml) followed by dichloromethane (100 ml, 4x). The
dichloromethane layers were combined, dried over sodium sulfate and then concentrated in
vacuo to a colorless oil. The oil was dissolved in dichloromethane (15 ml), diethyl ether was
added until the solution was cloudy and placed at -80°C overnight. The white solid that
precipitated was filtered and washed with cold ether. Total yield, 7.5 grams (24 mmol, 56%
yield). 13C NMR (CDCl3, 300 MHz) δ 155.99, 81.73, 80.43, 50.66, 41.17, 37.17, 31.67, 28.32,
28.04. 1H NMR (CDCl3, 300 MHz) 5.65 (s, 1H), 3.21 (q, 2H), 2.72-2.48 (m, 21H), 1.44 (s, 9H).
HR-FAB, m/z 316.2728 (M+H) theoretical 316.2712.
(N-Boc-2-aminoe thy l) -4 ,7,10-t ri (t -butoxycarbonylmethy l)-cy c len (3) . A solution
of 2 (950 mg, 3 mmol), sodium carbonate (3.3 g, 31 mmol) and t–butyl bromoacetate (2.4 ml,
15 mmol) in acetonitrile (100 ml) was stirred at 70°C overnight. The following day, the
reaction was filtered and washed with heptane (250 ml, 3x). The acetonitrile layer was then
concentrated in vacuo to a pale yellow oil. The oil was dissolved in dichloromethane (15 ml),
heptane was added until the solution was cloudy and placed at –80°C overnight. The white
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solid that precipitated was filtered and washed with heptane. Total yield, 1.68 grams (2.5 mmol,
85% yield). 13C NMR (CDCl3, 300 MHz) δ 173.36, 172.84, 172.58, 156.42, 82.80, 81.42, 81.94,
79.20, 56.51, 55.69, 53.95, 50.34 (m), 37.84, 28.41, 28.01, 27.82. 1H NMR (CDCl3, 300 MHz)
5.43 (s, 1H), 3.4 - 2.2 (m, 26H), 1.6-1.4 (m, 36H). HR-FAB, m/z 658.4750 (M+H) theoretical
658.4754.
1-Aminoethyl-4 ,7,10-t ri( carboxymethy l)-cy clen (4) . A solution of 3 (1.6 grams, 2.5
mmol) in triisopropyl silane (500 µl) and trifluoroacetic acid (50 ml) was stirred overnight at
room temperature. The following day the solution had turned orange and the solvent was
removed in vacuo until less than 1 ml remained. The remained solution was added dropwise to
cold diethyl ether. The pale orange solid that formed immediately was filtered, and then
resuspended in a minimal amount of water (~3 ml). The final product was titurated and
filtered off by the addition of a large excess of acetone (~100 ml). Total yield, 420 mg (1.1
mmol, 45% yield). 13C NMR (D2O, 500 MHz) δ 175.70, 170.50, 57.31, 52.69, 52.27, 50.60,
50.30, 48.39, 48.17, 36.29. 1H NMR (D2O, 500 MHz) 3.8-2.6 (m). HR-FAB, m/z 390.2355
(M+H) theoretical 390.2352.
1-(Aminoethyl)-4 ,7 ,10-t ri (carboxymethy l)-cy clen,  gadolinium salt (5a) . A solution
of 4 (289 mg, 743 µmols) and gadolium chloride (235 mg, 891 µmols) was stirred at 80° C
overnight. The pH was periodically checked and adjusted to 6.0~7.0 using a solution of
lithium hydroxide (1M) as needed. After 12 hours, lithium hydroxide was added to bring the
pH to ~12 and reaction was syringed through a nylon .2 µm filter. The filtrate was then
lypohilized to a white powder that was resuspended in a minimal amount of methanol (~1 ml).
The final product was titurated from this solution and filtered off by the addition of a large
excess of acetone (~40 ml). This solution was purified over an ion-exchange resion (Bio-Rad
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Chelex), dialyzed (100 MWCO) and lyophilized to an off-white powder. Total yield, 242 mg
(446 µmols, 50% yield). HR-FAB, m/z 545.1361 (M+H) theoretical 545.1358.
1-(Aminoethyl)-4 ,7 ,10-t ri (carboxymethy l)-cy clen,  t e rbium salt (5b).  This
compound was made in a fashion similar to 5a. Total yield, 325 mg (596 µmols, 80% yield).
HR-FAB, m/z 546.1384 (M+H) theoretical 546.1376.
Characterization
The number of water molecules in the inner-coordination sphere (q) was indirectly
determined by measuring the fluorescent lifetimes of 5b in H2O and D2O (Figure 13). The O-
H oscillators present on the coordinated water molecule are efficient quenchers of the excited
state of 5b. However O-D oscillators are largely ineffective at quenching fluorescence,
therefore it is possible to indirectly determine the number of water molecules in both
coordination spheres by measuring the fluorescence lifetimes in D2O vs. H2O [67]. Nearby
water molecules in the outer coordination sphere also quench the excited state, albeit to a
lesser extent because of their relative distance from the metal center. This relationship between
the fluorescent lifetimes is modeled in Equation 17 [68, 69].
q = 5 kH2O − kD2O − 0.06( ) [17]
When the published correction factors for the presence of inner-sphere N-H
oscillators were incorporated into Equation 17, q was 0, which is unreasonable considering
the crystallographic evidence to the contrary. The uncorrected lifetime data was used instead,
indicating q = 0.6. The estimated error of this method is approximately ±0.5. Non-integral
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results are also indicative of the equilibrium distribution of the complex where there is one or
no water molecules bound.
The spin-lattice relaxation times (T1) of the bulk water were measured in order to
estimate the relaxivity (r1) of 5a. The relationship between T1 and r1 is given in Equation 18,
where T1








 Because relaxivities varies with field strength (Table 2), measurements were made at
several common field strengths used in both MRI and µMRI applications. The buffer system
with phosphate and carbonate anions most closely resembles in vivo conditions, while the

































y = -0.6559x + 7.8181
D2O Fit
y = -0.4143x + 7.7615
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second facilitates comparison with relaxivities of other CAs that were measured in phosphate-
and carbonate-free buffer systems [70, 71]. These numbers are typical of a small-molecule CA
with a single coordinated water molecule [72].
Using a model for MRI contrast enhancement for T1 agents it is possible to evaluate
the utility of 5a as the “on” component of a relaxometric probe [63]. Using the r1 data
obtained for 5a, the relaxivities for the “off” state that will lead to an acceptable signal-to-noise
at an intracellular concentration of 1mM were estimated to be 1.6 mM-1s-1, 1.9 mM-1s-1, 2.2
mM-1s-1 or 1.8 mM-1s-1 at 60MHz, 300MHz, 500MHz and 600MHz, respectively. These
relaxivities represent the smallest-detectable relaxivity change in the Xenopus (African horned
frog) embryo. Given the relaxivities of other “off” contrast agents [35, 36] and some q = 0
complexes [72], it seems reasonable to achieve the desired relaxivity of the “off” component of
the relaxometric probe.
Single crystals of 4 and 5a were obtained by the slow diffusion of acetone into aqueous
solutions of the compounds. X-ray crystallography confirmed the structures (Figure 14).
Compound 5a crystallized with two conformational isomers (labeled A and B) in the
asymmetric unit. The two isomers differed mainly because of an inversion of the ethylene
Field Strength (MHz) Relaxivity (mM-1s-1)












Table 2: Relaxivity of 5a. All relaxivities taken at 25° C and pH 7.2, except for the 60MHz data
taken at 37° C.
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linker to the pendant amine. The torsion angle GdA-N4A-C15A-C16A was 53.8° while GdB-
N5B-C15B-C16B was 12.3°. The coordinated atoms are arranged in a monocapped twisted
square antiprism, with N1A, N2A, N3A and N4A composing one plane (rms deviation =
0.0170 Å) 1.638 Å below GdA while N5A, O1A, O2A, O3A and N5A line on the second
plane (rms deviation = 0.0352 Å) 0.762 Å above GdA. The planes are twisted approximately
37° relative to each other.
Discussion
We succeeded in the synthesis and characterization of gadolinium and terbium
complexes of AEDO3A. The relaxation and fluorescent lifetime indicate a potential for the
inclusion of AE-DO3A-Gd into a relaxometric probes. The cystallographic data indicate the
pendant amine is coordinated to the metal center, a favorable position to serve as an anchor
for an effector moiety expected to modulate the inner coordination sphere.
Figure 14. Displacement ellipsoid plots of 4 and 5a with 50% surfaces. Selected bond
lengths from 5a: Gd-N5A = 2.597(2) Å, Gd-N5B = 2.560 Å, Gd-N(1-4)(A-B) = 2.637(2) –
2.714(2) Å, Gd-OA 2.471(2) Å, Gd-OB 2.508 Å, Gd-O(1-3)(A-B) = 2.3284(17) – 2.3660(19) Å.
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C h a p t e r  5
ASP-DO3A – ATTEMPT AT AN APOPTOSIS-SENSITIVE RELAXOMETRIC
PROBE
1-(2-Aspartryl-aminoethyl)-4,7,10-tri(carboxymethyl)-cyclen (Asp-AEDO3A) is
evaluated as the second component of an apoptosis-sensitive relaxometric probe system. The
synthesis and characterization of the ligand and its Gd and Tb complexes is described.
Fluorescence lifetime data of the terbium complex indicate the presence of 0.6 water
molecules in the inner coordination sphere. The gadolinium complex has a relaxivity of
1.4mM-1s-1 and 1.7 mM-1s-1 at 60Mhz and 500MHz, respectively. Toxicity studies
demonstrated Xenopus embryos tolerated Asp-AEDO3A•Gd at magnetically useful
concentrations as predicted by tissue contrast modeling. X-ray crystallography data are
presented for both the ligand and gadolinium complex.
Synthesis
Asp-AEDO3A was synthesized in a manner nearly identical to AEDO3A. All reagents
and solvents were purchased from Aldrich, Fluka, or Strem (cyclen) and were used without
further purification. Ion exchange resins purchased from Bio-Rad.
Boc-Asp(Ot-Bu)-e thylbromide  (6).  A 1N solution of sodium hydroxide (65 ml) was
added dropwise over 15 minutes to a vigorously stirring biphasic system of bromoethylamine
hydrobromide (6.41 g, 32 mmol) in water (50 ml) and N-(Boc-Aspartyloxy)-succinimide t-butyl
ester (6.05 g, 16 mmol) in dichloromethane (50 ml). After 2 hours, the layers were separated
and the organic layer was washed with 1H HCl (25 ml) twice and a saturated sodium chloride
(25 ml) once.
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The organic layer was then dried over sodium sulfate and concentrated in vacuo to a
colorless oil. The oil was dissolved in hexanes (5 ml) and placed at –80° C overnight. The
white solid that crystallized was filtered and washed with cold hexanes. Total yield, 5.08 grams
(12.9 mmol or 82% yield). Total yield, 420 mg (1.1 mmol, 45% yield). 13C NMR (CDCl3, 300
MHz) δ 171.16, 155.58, 81.72, 80.42, 50.68, 41.17, 37.26, 31.63, 28.32, 28.04. 1H NMR (CDCl3,
Scheme 2: Synthetic Scheme for Asp-AEDO3A. a) Boc-Asp(Ot-Bu)-OSu, NaOH, DCM/H2O,
yield 82%; b) cyclen, MePh, yield 53%; c) t-Butyl bromoacetate, Na2CO3, yield 54%; d) TFA,











































































300 MHz) 7.06 (s, 1H), 6.74 (s, 1H), 4.47 (s, 1H), 3.66 (t, 2H), 4.45 (t, 2H), 2.89-2.61 (m, 2H),
1.45 (s, 18H). HR-FAB, m/z 395.1189 (M+H) theoretical 395.1181.
1-( (N-Boc-Asparty l )aminoethyl)-cyc len t -buty l es te r (7) .  A solution of (N-Boc-
aspartyl) aminoethylbromide (5.03 g, 12.9 mmol) and cyclen (15.5 g, 90 mmol) in
dichloromethane (250 ml) was stirred at reflux for 48 hours. The mixture was then washed
with water (100 ml, 3x). The organic layer was then concentrated in vacuo and resuspended in
toluene (100 ml). The product was extracted from toluene solution with water (100 ml, 3x).
The combined aqueous layers were washed with toluene (50 ml) followed by dichloromethane
(100 ml, 4x). The dichloromethane layers were combined, dried over sodium sulfate and then
concentrated in vacuo to a colorless oil. The oil was dissolved in dichloromethane (15 ml),
heptane was added until the solution was cloudy and placed at –80°C overnight. The white
solid that precipitated was filtered and washed with heptane. Total yield, 3.32 grams (6.8 mmol,
53% yield). 13C NMR (CDCl3, 300 MHz) δ 171.16, 170.59, 155.45, 81.19, 79.94, 51.27, 47.84,
46.39, 45.82, 38.71, 38.20, 37.71, 28.36. 1H NMR (CDCl3, 300 MHz) 5.8 (broad, 1H), 4.4
(broad, 1H), 3.5-2.4 (m, 22H), 1.47 (s, 18H). HR-FAB, m/z 487.3624 (M+H) theoretical
487.3607.
1-( (N-Boc-Asparty l )aminoethyl)-4 ,7 ,10-t ri (t -butoxycarbonylmethy l)-cy c len (8) . A
solution of 1-((boc-aspartyl)aminoethyl)-cyclen t-butyl ester (1.35 g, 2.8 mmol), sodium
carbonate (2.9 g, 27 mmol) and t–butyl bromoacetate (2.7 ml, 13.9 mmol) in acetonitrile (100
ml) was stirred at 70°C overnight. The following day, the reaction was filtered and washed with
heptane (250 ml, 3x). The acetonitrile layer was then concentrated in vacuo to a pale yellow oil.
The oil was dissolved in diethyl ether (10 ml), pentane was added until the solution was cloudy
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and placed at –80°C overnight. The white solid that precipitated was filtered and washed with
pentane. Total yield, 1.22 grams (1.5 mmol, 54% yield). 13C NMR (CDCl3, 500 MHz) δ 173.58,
172.67, 171.35, 170.99, 155.59, 82.86, 82.51, 81.44, 80.13, 55.83 (broad), 53.64, 51.3 (broad),
36.33, 28 (m). 1H NMR (CDCl3, 300 MHz)7.22 (s, 1H), 5.76 (d, 1H), 4.41 (d, 1H), 3.4-2.2 (m,
28H), 1.49-1.43 (m, 45H). HR-FAB, m/z 829.5684 (M+H) theoretical 829.5649.
1-Asparty laminoethy l-4 ,7,10-t ri( carboxymethy l)-cy clen (9) . A solution of 1-((Boc-
aspartyl) aminoethyl)-4,7,10-tri(t-butoxycarbonylmethyl)-cyclen t-butyl ester (685 mg, 826
µmol) in triisopropylsilane (500 µl) and trifluoroacetic acid (50 ml) was stirred overnight at
room temperature. The following day the solution had turned orange and the solvent was
removed in vacuo until approximately 1 ml remained. The remained solution was added
dropwise to cold diethyl ether. The pale orange solid that formed immediately was filtered, and
then resuspended in a minimal amount of water (~1 ml). The product was titurated and
filtered off by the addition of a large excess of acetone (~100 ml). Total yield, 269 mg (533
µmol, 65% yield). 13C NMR (CDCl3, 500 MHz) δ 175.60, 174.18, 172.66, 170.49, 57.35, 52.71,
52.33, 50.71, 50.63, 50.36, 48.46, 48.23, 36.37, 34.62. 1H NMR (CDCl3, 300 MHz) 4.2-2.4 (m).
HR-FAB, m/z 505.2623 (M+H) theoretical 505.2621.
1-Asparty laminoethy l-4 ,7,10-t ri( carboxymethy l)-cy clen,  gadolinium salt (10a) . A
solution of 1-(aspartylaminoethyl)-4,7,10-tri(carboxymethyl)-cyclen (167 mg, 331 µmols) and
gadolium chloride (120 mg, 457 µmols) was stirred at 80° C overnight. The pH was
periodically checked and adjusted to 6.0 ~ 7.0 using a solution of lithium hydroxide (1M) as
needed. After 12 hours, lithium hydroxide was added to bring the pH to ~12 and reaction was
syringed through a nylon .2 µm filter. The filtrate was then lypohilized to a white powder that
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was resuspended in a minimal amount of methanol (~1 ml). The final product was precipitated
from this solution by the addition of a large excess of acetone (~40 ml) and filtered off. The
precipitate was collected as resuspended in water. This solution was purified over an ion-
exchange resin (Bio-Rad Chelex), dialyzed (100 MWCO) and lyophilized to an off-white
powder. Total yield, 160 mg (243 µmols, 73% yield). HR-FAB, m/z (M+H) theoretical
545.1358.
1-Asparty laminoethy l-4 ,7,10-t ri( carboxymethy l)-cy clen,  t e rbium salt (10b) . This
compound was made in a fashion similar to 10a. Total yield, 160 mg (243 µmols, 73% yield).
HR-FAB, m/z (M+H) theoretical 545.1358.
Characterization
The number of water molecules in the inner-coordination sphere (q) was estimated for
10b in a fashion similar to 5b (Figure 15). The uncorrected lifetime data indicated a q of 0.45.
The relaxivities of 10a were estimated in a fashion similar to 5a (Table 3).
Figure 15: Fluorescent Lifetime Data of Asp-AEDO3A-Tb.
























y = -0.3244x + 3.73
D2O Fit
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At this point, a preliminary evaluation was made of the utility of 5a and 10a as a
relaxometric probe system. Tissue contrast modeling [63] indicated the lowest intracellular
concentration of this relaxometric probe that would lead to an acceptable signal-to-noise in the
Xenopus embryo is 0.7 mM. Microinjection experiments confirmed the embryos tolerated
intracellular concentrations as great as 4 mM (Figure 16), well above the theoretical limit of
detection.
Unfortunately, in vitro measurement of the enzymatic hydrolysis failed to detect any
cleavage of 10a. The enzyme assays were repeated under numerous conditions of enzyme
concentration, temperature, buffer composition and enzyme source, however no cleavage was
detected in any experiment. Competitive inhibition assays indicates that 10a is recognized by
and binds to caspase-3 reasonably well (Km=1.3 mM).
Single crystals of 10a were obtained by the slow diffusion of acetone into an aqueous
solution of the compound. X-ray crystallography confirmed the structures (Figure 17). The
coordinated atoms are arranged in a monocapped twisted square antiprism, with N1, N2, N3
and N4 composing one plane (rms deviation = 0.0068 Å) 1.665 Å below GdA while N5, O1,
Field Strength (MHz) Relaxivity (mM-1s-1)












Table 3: Relaxivity of 10a. All relaxivities taken at 25° C and pH 7.2, except for the 60MHz
data taken at 37° C.
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O2, O3 and N5 line on the second plane (rms deviation=0.0562 Å) 0.892 Å above GdA. The
planes are twisted approximately 23.4 ° relative to each other.
Close inspection of the X-ray structure provided a likely explanation for the negative
results in the in vitro cleavage assay. The proton on the amide nitrogen has been replaced by the
gadolinium ion (Figure 17, Panels B and C). The deprotonation and subsequent coordination
Figure 16. Brightfield and fluorescence images of Xenopus embryos with 40nl of a 100 mM
solution 10a with 5mg/ml Rhodamine-Dextran as a fluorescent tracer. All embryos were
injected prior to stage 3.
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of a carboxamide by a metal ion is a well-studied phenomenon. In fact, in the well-known
Biuret assay for proteins a Cu2+ ion substitutes for amide protons on the peptide backbone of
proteins to form a colored complex, enabling the facile spectrophotometric determination of
protein concentration.
Furthermore, the cleavage of N-carboxamido metal complexes at the coordinated
amide bonds has also been investigated [73-75]. N-carboxamido metal coordination inhibits
the hydrolysis of the amide bond to such a degree that the rate of hydrolysis has never been
measured [76]. Although steric effects certainly play some role, this effect is primarily
electronic in origin. Cleavage at an amide is preceded by the polarization of the carbonyl,
Figure 17. Three displacement ellipsoid plots of 10a  with 50% surfaces. Panel a. A
perspective overview of the complex. Panel b. The non-coordinated atoms from the
macrocycle and carboxymethyl arms have been removed for clarity. The distances between
the labeled atoms and the gadolinium (center, not labeled) are shown. Panel c. The sum of
angles (359.99°) among atoms bonded to the amide confirms sp2 hybridization.
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activatating the carbonyl-carbon for nucleophilic attack. When an amide bond is metalated at a
deprotonated amide nitrogen, the carbonyl can no longer be polarized and hence becomes
nearly impervious to nucleophilic attack.
Although the stability of this bond in physiological conditions has not been confirmed,
there is no question this bond exists in the solid state and was formed in an aqueous solution.
As such, this breaks new and exciting ground in multiple ways, overshadowing the failure of
this contrast agent to be cleaved by caspase.
Not only will this be the first reported example of any actinide or lanthanide
substituting for the proton of a carboxamide in aqueous solution, it will be the first ever-
reported N-carboxamido actinide or lanthanide complex. Although this is of general interest to
the inorganic chemistry community, the N-carboxamido coordination has the potential to
significant impact the future of MRI CA design, perhaps enabling a new generation of CAs
with relaxivities an order of magnitude greater than is presently possible. Further work is
certainly warranted on the nature of this bond, its formation and interactions with the metal
ion.
Discussion
We succeeded in the synthesis and characterization of gadolinium and terbium
complexes of Asp-AEDO3A. Although the relaxation, fluorescence lifetime, and toxicity
results are all favorable for inclusion into a relaxometric probe, unfortunately caspase never
cleaved this bond. However, the disappointment at this failure is tempered by the discovery of
a novel coordination chemistry for gadolinium.
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C h a p t e r  5
CONCLUSION
A novel and potentially useful contrast agent, AEDO3A•Gd, was synthesized and
characterized. This is the first MRI DO3A-derivative containing a pendant amine and may
potentially prove useful to other researchers investigating bifunctional contrast-agents or other
relaxometric probes. During the course of this investigation, novel methods were developed to
reduce the uncertainty in relaxivity estimates, allowing the comparison of relaxivities to be
more confidently made.
However the most exciting discovery was the novel coordination chemistry rendering
Asp-AEDO3A•Gd resistant to enzymatic hydrolysis. The N-carboxamido coordination of
exhibited in Asp-AEDO3A•Gd has the potential to permit the synthesis of a novel class CAs.
Attempts to generate high-relaxivity contrast agents eventually come up against τm – water
exchange rates of gadolinium complexes are simply too long and cannot be increased without
decreasing the thermodynamic stability of the CA, which would nullify their utility in vivo.
Consequently, researchers designing high-relaxivity CAs have focused on exotic oxidation
states in metal ions that are normally non-relaxogenic. A most promising example of this is
Eu2+. Its complexes have τm’s two orders of magnitude quicker than most gadolinium
complexes and coupling a Eu2+-based CAs to a slowly tumbling macromolecule to increase τR,
might potentially produce a contrast agent with a relaxivities measured in the hundreds.
Unfortunately, Eu2+ is not redox-stable in aqueous solutions and much effort has been
devoted to finding a good redox-stabilizing ligand for Eu2+ that would also ameliorate its
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toxcicity. N-carboxamido metal are excellent π-donors and have been used to stabilize other
redox sensitive metal ions. Further research into this area is certainly warranted.
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Crystal Structure Analysis of AEDO3A
Table A.1.1. Crystal data
Table A.1.2. Atomic Coordinates
Table A.1.3. Full bond distances
Table A.1.4. Full bond angles
Table A.1.5. Anisotropic displacement parameters
Table A.1.6. Hydrogen atomic coordinates
Table A.1.7. Hydrogen bond distances and angles
Crystallographic data have been deposited with the CCDC as supplementary
publication CCDC 175662. These data can be obtained free of charge via
http://www.ccdc.cam.ac.uk/ conts/retrieving.html (or from CCDC, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: +44 1223 335033; or deposit@ccdc.cam.ac.uk). Structure
factors are available from the author via email: xray@caltech.edu.
Table A.1.1. Crystal data and structure refinement for AEDO3A.








Type of diffractometer Bruker SMART 1000
Wavelength 0.71073 Å MoKα
Data Collection Temperature 98(2) K
θ range for 15223 reflections used in
lattice determination
2.29 to 28.09°
Unit cell dimensions a = 7.7997(5) Å
b = 16.6844(11) Å β= 92.1710(10)°





Density (calculated) 1.378 Mg/m3
F(000) 1040
Data collection program Bruker SMART v5.054
θ range for data collection 1.67 to 28.19°
Completeness to θ = 28.19° 95.7 %
Index ranges -10 ≤ h ≤ 10, -22 ≤ k ≤ 22, -23 ≤ l ≤ 23
Data collection scan type ω scans at 7 φ settings
Data reduction program Bruker SAINT v6.22
Reflections collected 46047
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Table A.1.1. Crystal data and structure refinement for AEDO3A.
Independent reflections 5450 [Rint= 0.0610]
Absorption coefficient 0.115 mm-1
Absorption correction None
Max. and min. transmission 0.9749 and 0.9627
Structure solution and Refinement
Structure solution program SHELXS-97 (Sheldrick, 1990)
Primary solution method Direct methods
Secondary solution method Difference Fourier map
Hydrogen placement Difference Fourier map
Structure refinement program SHELXL-97 (Sheldrick, 1997)
Refinement method Full matrix least-squares on F2
Data / restraints / parameters 5450 / 0 / 453
Treatment of hydrogen atoms Unrestrained
Goodness-of-fit on F2 1.749
Final R indices [I>2σ(I), 3978
reflections]
R1 = 0.0390, ωR2 = 0.0584
R indices (all data) R1 = 0.0577, ωR2 = 0.0597
Type of weighting scheme used Sigma
Weighting scheme used w=1/σ2(Fo2)
Max shift/error 0.000
Average shift/error 0.000
Largest diff. peak and hole 0.362 and -0.274 e.Å-3
Special Refinement Details
Refinement of F2 against ALL reflections. The weighted R-factor (wR) and goodness of fit (S) are based on F2,
conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold expression of F2 >
2σ( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement.
R-factors based on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data
will be even larger.
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion
angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An
approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
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Table A.1.2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters
(Å2 x 103) for AEDO3A. Ueq is defined as the trace of the orthogonalized Uij tensor.
x y z Ueq
O(1) 1923(1) -2606(1) 2211(1) 25(1)
O(2) 3685(1) -1658(1) 2695(1) 19(1)
O(3) 7023(1) -69(1) 4607(1) 18(1)
O(4) 7691(1) 1222(1) 4741(1) 18(1)
O(5) 5369(1) 84(1) 2969(1) 17(1)
O(6) 3382(1) 489(1) 2109(1) 18(1)
N(1) 6496(1) -2319(1) 2140(1) 15(1)
N(2) 8075(1) -1988(1) 3667(1) 14(1)
N(3) 9008(1) -264(1) 3362(1) 14(1)
N(4) 7280(1) -655(1) 1908(1) 15(1)
N(5) 4761(2) -1263(1) 4161(1) 16(1)
C(1) 8048(2) -2747(1) 2463(1) 16(1)
C(2) 8018(2) -2787(1) 3311(1) 16(1)
C(3) 9855(2) -1691(1) 3684(1) 16(1)
C(4) 10016(2) -812(1) 3886(1) 16(1)
C(5) 9861(2) -202(1) 2614(1) 17(1)
C(6) 8551(2) -4(1) 1997(1) 17(1)
C(7) 7888(2) -1259(1) 1378(1) 17(1)
C(8) 6785(2) -2004(1) 1362(1) 17(1)
C(9) 4895(2) -2815(1) 2152(1) 19(1)
C(10) 3364(2) -2309(1) 2369(1) 17(1)
C(11) 7436(2) -2052(1) 4434(1) 17(1)
C(12) 5501(2) -2037(1) 4449(1) 19(1)
C(13) 8836(2) 551(1) 3711(1) 15(1)
C(14) 7748(2) 561(1) 4404(1) 15(1)
C(15) 5605(2) -325(1) 1681(1) 16(1)
C(16) 4726(2) 113(1) 2310(1) 15(1)
O(21) 2050(1) 449(1) 663(1) 24(1)
O(22) 3129(1) 817(1) 3947(1) 23(1)
O(23) 9172(1) 2612(1) 4280(1) 26(1)
O(24) 4955(2) -1222(1) -84(1) 32(1)
O(25) 1239(1) -993(1) -82(1) 27(1)
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Table A.1.3. Bond lengths [Å] for AEDO3A.
O(1)-C(10) 1.2501(15) C(5)-C(6) 1.5073(18)
O(2)-C(10) 1.2520(15) C(5)-H(5A) 1.007(12)
O(3)-C(14) 1.2521(15) C(5)-H(5B) 0.987(13)
O(4)-C(14) 1.2560(15) C(6)-H(6A) 1.006(12)
O(5)-C(16) 1.2570(14) C(6)-H(6B) 0.986(13)
O(6)-C(16) 1.2616(14) C(7)-C(8) 1.5121(19)
N(1)-C(9) 1.4996(17) C(7)-H(7A) 0.997(13)
N(1)-C(1) 1.5006(16) C(7)-H(7B) 1.000(12)
N(1)-C(8) 1.5042(17) C(8)-H(8A) 0.996(12)
N(1)-H(1) 0.917(14) C(8)-H(8B) 0.970(13)
N(2)-C(11) 1.4721(16) C(9)-C(10) 1.5239(18)
N(2)-C(3) 1.4738(16) C(9)-H(9A) 0.964(13)
N(2)-C(2) 1.4756(16) C(9)-H(9B) 0.983(13)
N(3)-C(13) 1.5027(16) C(11)-C(12) 1.5109(19)
N(3)-C(4) 1.5052(16) C(11)-H(11A) 1.001(12)
N(3)-C(5) 1.5116(16) C(11)-H(11B) 0.967(13)
N(3)-H(3) 0.938(13) C(12)-H(12A) 0.978(13)
N(4)-C(15) 1.4597(16) C(12)-H(12B) 0.985(12)
N(4)-C(7) 1.4690(16) C(13)-C(14) 1.5221(18)
N(4)-C(6) 1.4748(16) C(13)-H(13A) 0.939(12)
N(5)-C(12) 1.4960(17) C(13)-H(13B) 0.979(13)
N(5)-H(5C) 0.948(15) C(15)-C(16) 1.5208(18)
N(5)-H(5D) 0.928(14) C(15)-H(15A) 0.952(12)
N(5)-H(5E) 0.984(16) C(15)-H(15B) 1.008(12)
C(1)-C(2) 1.5095(18) O(21)-H(21A) 0.849(17)
C(1)-H(1A) 0.981(12) O(21)-H(21B) 0.874(18)
C(1)-H(1B) 0.997(11) O(22)-H(22A) 0.905(17)
C(2)-H(2A) 1.004(12) O(22)-H(22B) 0.867(17)
C(2)-H(2B) 0.998(12) O(23)-H(23A) 0.856(19)
C(3)-C(4) 1.5141(18) O(23)-H(23B) 0.885(18)
C(3)-H(3A) 1.029(13) O(24)-H(24A) 1.01(2)
C(3)-H(3B) 0.965(12) O(24)-H(24B) 0.95(2)
C(4)-H(4A) 0.964(12) O(25)-H(25A) 0.864(17)
C(4)-H(4B) 0.997(12) O(25)-H(25B) 0.833(17)
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Table A.1.4. Bond Angles [°] for AEDO3A.
C(9)-N(1)-C(1) 113.07(11) C(5)-C(6)-H(6B) 107.8(7)
C(9)-N(1)-C(8) 111.04(11) H(6A)-C(6)-H(6B) 107.6(10)
C(1)-N(1)-C(8) 111.76(10) N(4)-C(7)-C(8) 112.32(11)
C(9)-N(1)-H(1) 106.3(8) N(4)-C(7)-H(7A) 112.2(7)
C(1)-N(1)-H(1) 109.1(8) C(8)-C(7)-H(7A) 107.9(7)
C(8)-N(1)-H(1) 105.1(8) N(4)-C(7)-H(7B) 108.5(7)
C(11)-N(2)-C(3) 110.96(10) C(8)-C(7)-H(7B) 109.4(7)
C(11)-N(2)-C(2) 109.03(10) H(7A)-C(7)-H(7B) 106.2(10)
C(3)-N(2)-C(2) 109.01(10) N(1)-C(8)-C(7) 111.95(11)
C(13)-N(3)-C(4) 110.30(10) N(1)-C(8)-H(8A) 107.4(7)
C(13)-N(3)-C(5) 110.50(10) C(7)-C(8)-H(8A) 110.2(7)
C(4)-N(3)-C(5) 110.36(10) N(1)-C(8)-H(8B) 107.5(8)
C(13)-N(3)-H(3) 107.3(8) C(7)-C(8)-H(8B) 110.9(7)
C(4)-N(3)-H(3) 110.6(8) H(8A)-C(8)-H(8B) 108.8(10)
C(5)-N(3)-H(3) 107.6(8) N(1)-C(9)-C(10) 110.98(11)
C(15)-N(4)-C(7) 112.87(10) N(1)-C(9)-H(9A) 107.9(7)
C(15)-N(4)-C(6) 110.08(10) C(10)-C(9)-H(9A) 108.3(7)
C(7)-N(4)-C(6) 109.99(10) N(1)-C(9)-H(9B) 107.2(8)
C(12)-N(5)-H(5C) 111.4(8) C(10)-C(9)-H(9B) 112.9(7)
C(12)-N(5)-H(5D) 112.3(8) H(9A)-C(9)-H(9B) 109.4(10)
H(5C)-N(5)-H(5D) 109.3(12) O(1)-C(10)-O(2) 127.55(12)
C(12)-N(5)-H(5E) 107.8(8) O(1)-C(10)-C(9) 115.46(12)
H(5C)-N(5)-H(5E) 109.9(12) O(2)-C(10)-C(9) 116.98(11)
H(5D)-N(5)-H(5E) 106.0(12) N(2)-C(11)-C(12) 112.86(11)
N(1)-C(1)-C(2) 111.12(11) N(2)-C(11)-H(11A) 109.5(7)
N(1)-C(1)-H(1A) 105.6(7) C(12)-C(11)-H(11A) 108.0(7)
C(2)-C(1)-H(1A) 112.2(7) N(2)-C(11)-H(11B) 109.7(8)
N(1)-C(1)-H(1B) 108.1(6) C(12)-C(11)-H(11B) 109.0(7)
C(2)-C(1)-H(1B) 111.7(6) H(11A)-C(11)-H(11B) 107.7(10)
H(1A)-C(1)-H(1B) 107.9(9) N(5)-C(12)-C(11) 112.38(12)
N(2)-C(2)-C(1) 112.73(11) N(5)-C(12)-H(12A) 106.3(7)
N(2)-C(2)-H(2A) 109.0(7) C(11)-C(12)-H(12A) 108.1(7)
C(1)-C(2)-H(2A) 110.9(7) N(5)-C(12)-H(12B) 107.0(7)
N(2)-C(2)-H(2B) 110.4(7) C(11)-C(12)-H(12B) 112.5(7)
C(1)-C(2)-H(2B) 108.1(7) H(12A)-C(12)-H(12B) 110.5(11)
H(2A)-C(2)-H(2B) 105.4(9) N(3)-C(13)-C(14) 113.86(11)
N(2)-C(3)-C(4) 113.60(11) N(3)-C(13)-H(13A) 108.9(7)
N(2)-C(3)-H(3A) 109.8(7) C(14)-C(13)-H(13A) 108.3(8)
C(4)-C(3)-H(3A) 107.8(7) N(3)-C(13)-H(13B) 107.9(7)
N(2)-C(3)-H(3B) 107.7(7) C(14)-C(13)-H(13B) 109.2(7)
C(4)-C(3)-H(3B) 111.2(7) H(13A)-C(13)-H(13B) 108.6(10)
H(3A)-C(3)-H(3B) 106.5(10) O(3)-C(14)-O(4) 125.16(12)
N(3)-C(4)-C(3) 113.91(11) O(3)-C(14)-C(13) 119.68(12)
N(3)-C(4)-H(4A) 105.3(7) O(4)-C(14)-C(13) 115.14(11)
C(3)-C(4)-H(4A) 109.6(7) N(4)-C(15)-C(16) 113.67(11)
N(3)-C(4)-H(4B) 105.4(7) N(4)-C(15)-H(15A) 109.1(7)
C(3)-C(4)-H(4B) 111.3(7) C(16)-C(15)-H(15A) 105.6(8)
H(4A)-C(4)-H(4B) 111.0(10) N(4)-C(15)-H(15B) 112.2(7)
C(6)-C(5)-N(3) 110.25(11) C(16)-C(15)-H(15B) 109.0(7)
C(6)-C(5)-H(5A) 111.4(7) H(15A)-C(15)-H(15B) 106.8(10)
N(3)-C(5)-H(5A) 106.6(7) O(5)-C(16)-O(6) 125.54(12)
C(6)-C(5)-H(5B) 112.9(7) O(5)-C(16)-C(15) 119.43(11)
N(3)-C(5)-H(5B) 107.7(7) O(6)-C(16)-C(15) 115.03(11)
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Table A.1.4. Bond Angles [°] for AEDO3A.
H(5A)-C(5)-H(5B) 107.8(10) H(21A)-O(21)-H(21B) 111.6(16)
N(4)-C(6)-C(5) 110.56(11) H(22A)-O(22)-H(22B) 103.2(14)
N(4)-C(6)-H(6A) 107.7(7) H(23A)-O(23)-H(23B) 106.2(16)
C(5)-C(6)-H(6A) 110.8(7) H(24A)-O(24)-H(24B) 111.5(16)
N(4)-C(6)-H(6B) 112.3(7) H(25A)-O(25)-H(25B) 104.5(15
Table A.1.5. Anisotropic displacement parameters (Å2 x 104 ) for AEDO3A. The
anisotropic displacement factor exponent takes the form: -2π2[ h2 a*2U11 + … +
2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
O(1) 131(5) 363(6) 266(6) -95(5) 8(4) -38(5)
O(2) 189(5) 197(5) 186(5) -33(4) 7(4) 6(4)
O(3) 201(5) 159(5) 189(5) 5(4) 31(4) -37(4)
O(4) 209(5) 150(5) 183(5) -27(4) 37(4) -7(4)
O(5) 169(5) 204(5) 147(5) -15(4) 7(4) 11(4)
O(6) 145(5) 180(5) 204(5) 5(4) 7(4) 29(4)
N(1) 135(6) 145(6) 181(7) -32(5) 11(5) 2(5)
N(2) 140(6) 144(6) 146(6) -14(5) 20(5) -8(5)
N(3) 126(6) 151(6) 157(6) -7(5) 14(5) -7(5)
N(4) 139(6) 142(6) 158(6) -16(5) 13(5) 8(5)
N(5) 153(6) 160(7) 161(7) -3(5) 20(5) -5(5)
C(1) 115(7) 148(8) 207(8) -17(6) 4(6) 16(6)
C(2) 160(8) 139(8) 189(8) 5(6) 8(6) 3(6)
C(3) 139(7) 180(8) 170(8) -12(6) -1(6) 11(6)
C(4) 124(7) 189(8) 174(8) 8(6) -21(6) 6(6)
C(5) 163(7) 172(8) 175(8) -7(6) 56(6) -17(6)
C(6) 189(7) 171(8) 164(8) 13(6) 55(6) 11(6)
C(7) 175(8) 194(8) 150(8) -7(6) 24(6) 26(6)
C(8) 178(8) 189(8) 148(8) -21(6) 1(6) 29(6)
C(9) 152(7) 174(8) 228(9) -25(7) -3(6) -23(6)
C(10) 166(8) 247(8) 102(7) 22(6) 14(6) 10(6)
C(11) 196(8) 157(8) 151(8) 13(6) -3(6) 26(6)
C(12) 211(8) 163(8) 184(8) 27(7) 28(6) 15(6)
C(13) 160(8) 126(7) 166(8) -14(6) 4(6) -4(6)
C(14) 121(7) 183(8) 143(7) 16(6) -28(6) 20(6)
C(15) 170(7) 167(8) 154(8) 16(6) -2(6) 16(6)
C(16) 158(7) 119(7) 180(8) 8(6) 25(6) -34(6)
O(21) 276(6) 227(6) 206(6) -8(5) -34(5) -1(5)
O(22) 229(6) 270(6) 202(6) 23(5) 44(5) 61(5)
O(23) 303(6) 212(6) 248(7) 17(5) 3(5) -70(5)
O(24) 309(7) 284(6) 352(7) 56(5) -8(5) 11(6)
O(25) 247(7) 240(7) 304(7) 40(5) -18(5) 9(5)
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Table A.1.6. Hydrogen coordinates ( x 104 ) and isotropic displacement parameters (Å2 x
103) for AEDO3A.
x y z Uiso
H(1) 6294(17) -1873(8) 2426(8) 26(4)
H(1A) 8023(14) -3280(8) 2232(7) 10(3)
H(1B) 9087(15) -2462(7) 2292(6) 5(3)
H(2A) 6972(15) -3080(7) 3476(7) 13(3)
H(2B) 9013(15) -3119(7) 3496(6) 12(3)
H(3) 7896(18) -463(8) 3268(7) 27(4)
H(3A) 10591(16) -2011(7) 4071(7) 21(4)
H(3B) 10318(15) -1799(7) 3198(7) 10(3)
H(4A) 11194(16) -645(7) 3853(6) 12(3)
H(4B) 9583(15) -703(7) 4397(7) 10(3)
H(5A) 10420(15) -736(7) 2525(7) 15(3)
H(5B) 10778(16) 204(8) 2668(7) 18(4)
H(5C) 4428(17) -1299(8) 3643(9) 29(4)
H(5D) 5515(18) -837(8) 4232(8) 30(4)
H(5E) 3757(19) -1136(8) 4458(8) 36(4)
H(6A) 7914(15) 501(7) 2117(6) 11(3)
H(6B) 9171(16) 93(7) 1532(7) 22(4)
H(7A) 7924(15) -1049(7) 854(7) 16(4)
H(7B) 9094(15) -1405(7) 1531(7) 12(3)
H(8A) 7351(15) -2438(7) 1077(7) 12(3)
H(8B) 5668(17) -1897(7) 1124(7) 20(4)
H(9A) 5071(15) -3228(8) 2526(7) 21(4)
H(9B) 4737(16) -3063(7) 1652(7) 21(4)
H(11A) 7889(14) -1593(7) 4746(7) 12(3)
H(11B) 7851(15) -2542(8) 4667(7) 19(4)
H(12A) 5176(16) -2080(7) 4974(8) 20(4)
H(12B) 4964(16) -2468(8) 4144(7) 19(4)
H(13A) 8337(16) 902(7) 3352(7) 14(4)
H(13B) 9990(17) 745(7) 3850(7) 14(3)
H(15A) 4854(16) -753(7) 1536(7) 18(4)
H(15B) 5667(15) 42(7) 1232(7) 14(3)
H(21A) 1860(20) -19(10) 491(9) 47(6)
H(21B) 2450(20) 434(11) 1129(11) 64(6)
H(22A) 3830(20) 571(9) 3623(9) 51(5)
H(22B) 3320(20) 557(10) 4364(10) 52(6)
H(23A) 8810(20) 2179(11) 4476(10) 65(7)
H(23B) 8850(20) 2592(10) 3797(11) 61(6)
H(24A) 5890(30) -877(12) -301(12) 99(8)
H(24B) 3850(30) -1018(12) -212(12) 93(8)
H(25A) 250(20) -908(9) -303(9) 47(6)
H(25B) 1130(20) -1431(10) 136(9) 48(6)
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Table A.1.7. Hydrogen bonds for AEDO3A [Å and °].
D-H…A d(D-H) d(H…A) d(D…A) <(DHA)
N(1)-H(1)…O(2) 0.917(14) 2.139(13) 2.6756(14) 116.4(10)
N(1)-H(1)…N(4) 0.917(14) 2.372(13) 2.8759(15) 114.5(10)
N(3)-H(3)…O(5) 0.938(13) 2.218(13) 2.9544(14) 134.8(11)
N(3)-H(3)…N(4) 0.938(13) 2.468(13) 2.9422(15) 111.4(10)
N(5)-H(5C)…O(2) 0.948(15) 1.860(15) 2.7849(16) 164.5(12)
N(5)-H(5D)…O(3) 0.928(14) 1.846(15) 2.7571(15) 166.5(13)
N(5)-H(5E)…O(4)#1 0.984(16) 1.856(16) 2.7851(15) 156.3(12)
O(21)-H(21A)…O(25) 0.849(17) 1.968(17) 2.8061(16) 169.0(16)
O(21)-H(21B)…O(6) 0.874(18) 1.862(19) 2.7346(14) 175.1(18)
O(22)-H(22A)…O(5) 0.905(17) 1.887(18) 2.7921(14) 177.4(15)
O(22)-H(22B)…O(3)#1 0.867(17) 2.030(18) 2.8643(14) 161.2(16)
O(23)-H(23A)…O(4) 0.856(19) 1.887(19) 2.7309(14) 168.4(17)
O(23)-H(23B)…O(1)#2 0.885(18) 1.898(19) 2.7766(15) 171.8(17)
O(24)-H(24A)…O(21)#3 1.01(2) 1.90(2) 2.8917(16) 166.5(17)
O(24)-H(24B)…O(25) 0.95(2) 2.06(2) 2.9233(17) 151.3(18)
O(25)-H(25A)…O(21)#4 0.864(17) 2.032(17) 2.8763(16) 165.4(15)
O(25)-H(25B)…O(23)#5 0.833(17) 1.924(18) 2.7542(16) 174.7(16)







Crystal Structure Analysis of AEDO3A-Gd
Table A.2.1. Crystal data
Table A.2.2. Atomic Coordinates
Table A.2.3. Full bond distances
Table A.2.4. Full bond angles
Table A.2.5. Anisotropic displacement parameters
Table A.2.6. Hydrogen atomic coordinates
Table A.2.7. Hydrogen bond distances and angles
Crystallographic data have been deposited with the CCDC as supplementary
publication CCDC 204982. These data can be obtained free of charge via
http://www.ccdc.cam.ac.uk/ conts/retrieving.html (or from CCDC, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: +44 1223 335033; or deposit@ccdc.cam.ac.uk). Structure
factors are available from the author via email: xray@caltech.edu.
Table A.2.1. Crystal data and structure refinement for AEDO3A-Gd.








Type of diffractometer Bruker SMART 1000
Wavelength 0.71073 Å Mo Kα
Data Collection Temperature 98(2) K
θ range for 15223 reflections used in
lattice determination
2.42 to 28.19°
Unit cell dimensions a = 10.2547(5) Å α = 69.1670(10)°
b = 15.5284(8) Å β = 76.6460(10)°





Density (calculated) 1.773 Mg/m3
F(000) 1364
Data collection program Bruker SMART v5.054
θ range for data collection 1.53 to 28.36°
Completeness to θ = 28.19° 91.5 %
Index ranges -13 ≤ h ≤ 13, -20 ≤ k ≤ 20, -23 ≤ l ≤ 22
Data collection scan type ω scans at 7 φ settings
A-11
Table A.2.1. Crystal data and structure refinement for AEDO3A-Gd.
Data reduction program Bruker SAINT v6.022
Reflections collected 51532
Independent Reflections 11495 [Rint= 0.0531]
Absorption coefficient 2.715 mm-1
Absorption correction None
Structure solution and Refinement
Structure solution program SHELXS-97 (Sheldrick, 1990)
Primary solution method Direct methods
Secondary solution method Difference Fourier map
Hydrogen placement Geometric positions
Structure refinement program SHELXL-97 (Sheldrick, 1997)
Refinement method Full matrix least-squares on F2
Data / restraints / parameters 11495 / 38 / 717
Treatment of hydrogen atoms Riding
Goodness-of-fit on F2 1.234
Final R indices [I>2σ(I), 3978
reflections]
R1 = 0.0247, ωR2 = 0.0469
R indices (all data) R1 = 0.0380, ωR2 = 0.0490
Type of weighting scheme used Sigma
Weighting scheme used ω=1/σ2(Fo2)
Max shift/error 0.006
Average shift/error 0.000
Largest diff. peak and hole 1.211 and -0.666 e.Å-3
Special Refinement Details
Restraints were placed on the geometry of all water molecules or ligands. All O-H and H-H distances were set to
refine to a common target (within a reasonable esd). All distances and angles are listed in Tables A.2.3 and A.2.4
and hydrogen bonds distances and angles are listed in Table A.2.7.
Refinement of F2 against ALL reflections. The weighted R-factor (ωR) and goodness of fit (S) are based on F2,
conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold expression of F2 >
2σ(F2) is used only for calculating R-factors (gt) etc. and is not relevant to the choice of reflections for refinement.
R-factors based on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data
will be even larger.
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion
angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An
approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
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Table A.2.2. Atomic coordinates ( x 104 ) and equivalent isotropic displacement parameters
(Å2x 103) for AEDO3A-Gd. Ueq is defined as the trace of the orthogonalized Uij tensor.
x y z Ueq
Gd(A) 8153(1) 2985(1) 4434(1) 8(1)
O(1A) 7942(2) 4510(1) 4358(1) 14(1)
O(2A) 6623(2) 3324(1) 3544(1) 14(1)
O(3A) 9109(2) 2047(1) 3675(1) 12(1)
O(4A) 8252(2) 5677(1) 4763(1) 15(1)
O(5A) 4591(2) 3634(1) 3290(1) 23(1)
O(6A) 9138(2) 772(1) 3370(1) 15(1)
O(A) 9335(2) 3967(1) 2988(1) 14(1)
N(1A) 7977(2) 3193(1) 5919(2) 11(1)
N(2A) 5611(2) 3071(1) 5232(2) 12(1)
N(3A) 6696(2) 1440(1) 4867(2) 11(1)
N(4A) 9128(2) 1557(2) 5509(2) 14(1)
N(5A) 10658(2) 3212(2) 4414(2) 15(1)
C(1A) 6576(3) 2978(2) 6436(2) 15(1)
C(2A) 5558(3) 3428(2) 5933(2) 15(1)
C(3A) 4860(3) 2162(2) 5601(2) 14(1)
C(4A) 5236(3) 1579(2) 5053(2) 13(1)
C(5A) 7030(3) 729(2) 5624(2) 14(1)
C(6A) 8511(3) 673(2) 5583(2) 16(1)
C(7A) 8859(3) 1611(2) 6369(2) 16(1)
C(8A) 8900(3) 2578(2) 6391(2) 16(1)
C(9A) 8348(3) 4168(2) 5743(2) 13(1)
C(10A) 8148(3) 4838(2) 4896(2) 11(1)
C(11A) 4994(3) 3714(2) 4570(2) 15(1)
C(12A) 5413(3) 3541(2) 3733(2) 13(1)
C(13A) 7064(3) 1136(2) 4134(2) 12(1)
C(14A) 8553(3) 1317(2) 3697(2) 10(1)
C(15A) 10588(3) 1537(2) 5137(2) 17(1)
C(16A) 11356(3) 2424(2) 4906(2) 17(1)
Gd(B) 1882(1) 6946(1) 10590(1) 8(1)
O(1B) 864(2) 7907(1) 11317(1) 11(1)
O(2B) 3364(2) 6813(1) 11477(1) 13(1)
O(3B) 2169(2) 5396(1) 10717(1) 13(1)
O(4B) 756(2) 9177(1) 11636(1) 15(1)
O(5B) 5337(2) 6470(1) 11819(1) 18(1)
O(6B) 1774(2) 4170(1) 10403(1) 16(1)
O(B) 764(2) 5930(1) 12070(1) 13(1)
N(1B) 3212(2) 8552(1) 10109(1) 11(1)
N(2B) 4417(2) 6886(2) 9846(2) 11(1)
N(3B) 2164(2) 6619(2) 9125(1) 12(1)
N(4B) 873(2) 8256(2) 9419(2) 15(1)
N(5B) -589(2) 6634(2) 10670(2) 13(1)
C(1B) 4689(3) 8464(2) 9903(2) 13(1)
C(2B) 5094(3) 7824(2) 9413(2) 14(1)
C(3B) 4554(3) 6427(2) 9212(2) 16(1)
C(4B) 3595(3) 6792(2) 8643(2) 17(1)
C(5B) 1310(3) 7225(2) 8579(2) 17(1)
C(6B) 1370(3) 8195(2) 8563(2) 19(1)
C(7B) 1311(3) 9166(2) 9399(2) 17(1)
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Table A.2.2. Atomic coordinates ( x 104 ) and equivalent isotropic displacement parameters
(Å2x 103) for AEDO3A-Gd. Ueq is defined as the trace of the orthogonalized Uij tensor.
x y z Ueq
C(8B) 2813(3) 9229(2) 9358(2) 15(1)
C(9B) 2839(3) 8882(2) 10828(2) 13(1)
C(10B) 1370(3) 8652(2) 11289(2) 12(1)
C(11B) 5040(3) 6326(2) 10548(2) 15(1)
C(12B) 4560(3) 6560(2) 11342(2) 13(1)
C(13B) 1749(3) 5645(2) 9355(2) 14(1)
C(14B) 1933(3) 5024(2) 10220(2) 12(1)
C(15B) -635(3) 8161(2) 9627(2) 22(1)
C(16B) -1257(3) 7513(2) 10503(2) 20(1)
O(1) 2453(2) 510(1) 1672(2) 20(1)
O(2) 1759(2) 1560(1) 2632(2) 17(1)
O(3) 3907(3) 1845(2) 3270(2) 26(1)
O(4) 1560(2) 3424(1) 2108(1) 18(1)
O(5) 2533(3) 4671(2) 2703(2) 22(1)
O(6) 7395(2) 5418(1) 2330(2) 19(1)
O(7) 6062(2) 8262(2) 1744(2) 24(1)
O(8) 8511(2) 6486(1) 3031(2) 19(1)
O(9) 8216(2) 8349(1) 2458(2) 18(1)
O(10) 7332(2) 9545(2) 3311(2) 23(1)
O(11) 4435(2) 9277(1) 7398(1) 21(1)
O(12) 4306(2) 9378(1) 2327(2) 21(1)
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Table A.2.3. Bond lengths [Å] for AEDO3A-Gd.
Gd(A)-O(1A) 2.3284(17) Gd(B)-O(1B) 2.3480(18)
Gd(A)-O(3A) 2.3408(18) Gd(B)-O(3B) 2.3500(17)
Gd(A)-O(2A) 2.3660(19) Gd(B)-O(2B) 2.3564(19)
Gd(A)-OA 2.471(2) Gd(B)-OB 2.508(2)
Gd(A)-N(5A) 2.597(2) Gd(B)-N(5B) 2.560(2)
Gd(A)-N(3A) 2.650(2) Gd(B)-N(2B) 2.637(2)
Gd(A)-N(1A) 2.672(2) Gd(B)-N(1B) 2.652(2)
Gd(A)-N(4A) 2.672(2) Gd(B)-N(4B) 2.684(2)
Gd(A)-N(2A) 2.677(2) Gd(B)-N(3B) 2.715(2)
O(1A)-C(10A) 1.270(3) O(1B)-C(10B) 1.268(3)
O(2A)-C(12A) 1.272(3) O(2B)-C(12B) 1.268(3)
O(3A)-C(14A) 1.273(3) O(3B)-C(14B) 1.264(3)
O(4A)-C(10A) 1.244(3) O(4B)-C(10B) 1.248(3)
O(5A)-C(12A) 1.238(3) O(5B)-C(12B) 1.246(3)
O(6A)-C(14A) 1.242(3) O(6B)-C(14B) 1.257(3)
OA-HA1 0.70(3) OB-HB1 0.83(3)
OA-HA2 0.73(3) OB-HB2 0.71(3)
N(1A)-C(9A) 1.481(3) N(1B)-C(9B) 1.479(3)
N(1A)-C(1A) 1.487(4) N(1B)-C(8B) 1.485(3)
N(1A)-C(8A) 1.487(3) N(1B)-C(1B) 1.487(3)
N(2A)-C(11A) 1.480(3) N(2B)-C(11B) 1.487(3)
N(2A)-C(3A) 1.486(3) N(2B)-C(3B) 1.488(4)
N(2A)-C(2A) 1.495(4) N(2B)-C(2B) 1.492(3)
N(3A)-C(13A) 1.475(3) N(3B)-C(13B) 1.474(3)
N(3A)-C(4A) 1.481(3) N(3B)-C(4B) 1.493(4)
N(3A)-C(5A) 1.486(3) N(3B)-C(5B) 1.495(3)
N(4A)-C(6A) 1.485(4) N(4B)-C(7B) 1.486(4)
N(4A)-C(7A) 1.486(4) N(4B)-C(6B) 1.491(4)
N(4A)-C(15A) 1.491(4) N(4B)-C(15B) 1.505(4)
N(5A)-C(16A) 1.487(3) N(5B)-C(16B) 1.469(3)
N(5A)-H(5A1) 0.9200 N(5B)-H(5B1) 0.9200
N(5A)-H(5A2) 0.9200 N(5B)-H(5B2) 0.9200
C(1A)-C(2A) 1.506(4) C(1B)-C(2B) 1.513(4)
C(1A)-H(1A1) 0.9900 C(1B)-H(1B1) 0.9900
C(1A)-H(1A2) 0.9900 C(1B)-H(1B2) 0.9900
C(2A)-H(2A1) 0.9900 C(2B)-H(2B1) 0.9900
C(2A)-H(2A2) 0.9900 C(2B)-H(2B2) 0.9900
C(3A)-C(4A) 1.514(4) C(3B)-C(4B) 1.507(4)
C(3A)-H(3A1) 0.9900 C(3B)-H(3B1) 0.9900
C(3A)-H(3A2) 0.9900 C(3B)-H(3B2) 0.9900
C(4A)-H(4A1) 0.9900 C(4B)-H(4B1) 0.9900
C(4A)-H(4A2) 0.9900 C(4B)-H(4B2) 0.9900
C(5A)-C(6A) 1.504(4) C(5B)-C(6B) 1.501(4)
C(5A)-H(5A3) 0.9900 C(5B)-H(5B3) 0.9900
C(5A)-H(5A4) 0.9900 C(5B)-H(5B4) 0.9900
C(6A)-H(6A1) 0.9900 C(6B)-H(6B1) 0.9900
C(6A)-H(6A2) 0.9900 C(6B)-H(6B2) 0.9900
C(7A)-C(8A) 1.518(4) C(7B)-C(8B) 1.530(4)
C(7A)-H(7A1) 0.9900 C(7B)-H(7B1) 0.9900
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Table A.2.3. Bond lengths [Å] for AEDO3A-Gd.
C(7A)-H(7A2) 0.9900 C(7B)-H(7B2) 0.9900
C(8A)-H(8A1) 0.9900 C(8B)-H(8B1) 0.9900
C(8A)-H(8A2) 0.9900 C(8B)-H(8B2) 0.9900
C(9A)-C(10A) 1.522(4) C(9B)-C(10B) 1.522(4)
C(9A)-H(9A1) 0.9900 C(9B)-H(9B1) 0.9900
C(9A)-H(9A2) 0.9900 C(9B)-H(9B2) 0.9900
C(11A)-C(12A) 1.531(4) C(11B)-C(12B) 1.516(4)
C(11A)-H(11A) 0.9900 C(11B)-H(11C) 0.9900
C(11A)-H(11B) 0.9900 C(11B)-H(11D) 0.9900
C(13A)-C(14A) 1.527(4) C(13B)-C(14B) 1.518(4)
C(13A)-H(13A) 0.9900 C(13B)-H(13C) 0.9900
C(13A)-H(13B) 0.9900 C(13B)-H(13D) 0.9900
C(15A)-C(16A) 1.491(4) C(15B)-C(16B) 1.498(4)
C(15A)-H(15A) 0.9900 C(15B)-H(15C) 0.9900
C(15A)-H(15B) 0.9900 C(15B)-H(15D) 0.9900
C(16A)-H(16A) 0.9900 C(16B)-H(16C) 0.9900
C(16A)-H(16B) 0.9900 C(16B)-H(16D) 0.9900
O(1)-H(1E) 0.89(3) O(7)-H(7E) 0.78(3)
O(1)-H(1F) 0.80(3) O(7)-H(7F) 0.79(3)
O(2)-H(2E) 0.81(3) O(8)-H(8E) 0.75(3)
O(2)-H(2F) 0.84(3) O(8)-H(8F) 0.73(3)
O(3)-H(3E) 0.75(3) O(9)-H(9E) 0.86(3)
O(3)-H(3F) 0.81(3) O(9)-H(9F) 0.81(3)
O(4)-H(4E) 0.74(3) O(10)-H(10E) 0.75(3)
O(4)-H(4F) 0.80(3) O(10)-H(10F) 0.94(3)
O(5)-H(5E) 0.75(3) O(11)-H(11E) 0.99(3)
O(5)-H(5F) 0.71(3) O(11)-H(11F) 0.98(3)
O(6)-H(6E) 0.77(3) O(12)-H(12E) 0.75(3)
O(6)-H(6F) 0.71(3) O(12)-H(12F) 0.88(3)
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Table A.2.4. Bond Angles [°] for AEDO3A-Gd.
O(1A)-Gd(A)-O(3A) 143.67(7) O(1B)-Gd(B)-O(3B) 143.49(7)
O(1A)-Gd(A)-O(2A) 85.38(7) O(1B)-Gd(B)-O(2B) 80.26(6)
O(3A)-Gd(A)-O(2A) 84.65(6) O(3B)-Gd(B)-O(2B) 90.12(6)
O(1A)-Gd(A)-OA 73.00(7) O(1B)-Gd(B)-OB 72.42(6)
O(3A)-Gd(A)-OA 70.71(6) O(3B)-Gd(B)-OB 71.13(7)
O(2A)-Gd(A)-OA 71.27(7) O(2B)-Gd(B)-OB 71.34(7)
O(1A)-Gd(A)-N(5A) 86.28(7) O(1B)-Gd(B)-N(5B) 79.88(7)
O(3A)-Gd(A)-N(5A) 80.66(7) O(3B)-Gd(B)-N(5B) 86.16(7)
O(2A)-Gd(A)-N(5A) 142.29(7) O(2B)-Gd(B)-N(5B) 140.78(7)
OA-Gd(A)-N(5A) 71.12(7) OB-Gd(B)-N(5B) 70.54(7)
O(1A)-Gd(A)-N(3A) 141.34(7) O(1B)-Gd(B)-N(2B) 130.08(7)
O(3A)-Gd(A)-N(3A) 67.30(7) O(3B)-Gd(B)-N(2B) 74.98(7)
O(2A)-Gd(A)-N(3A) 73.75(7) O(2B)-Gd(B)-N(2B) 66.54(7)
OA-Gd(A)-N(3A) 126.84(7) OB-Gd(B)-N(2B) 124.85(7)
N(5A)-Gd(A)-N(3A) 129.58(7) N(5B)-Gd(B)-N(2B) 147.64(7)
O(1A)-Gd(A)-N(1A) 66.59(7) O(1B)-Gd(B)-N(1B) 66.37(7)
O(3A)-Gd(A)-N(1A) 141.04(6) O(3B)-Gd(B)-N(1B) 142.72(7)
O(2A)-Gd(A)-N(1A) 130.55(7) O(2B)-Gd(B)-N(1B) 71.07(7)
OA-Gd(A)-N(1A) 130.06(7) OB-Gd(B)-N(1B) 127.60(7)
N(5A)-Gd(A)-N(1A) 78.06(7) N(5B)-Gd(B)-N(1B) 128.73(7)
N(3A)-Gd(A)-N(1A) 103.10(7) N(2B)-Gd(B)-N(1B) 68.08(7)
O(1A)-Gd(A)-N(4A) 130.66(7) O(1B)-Gd(B)-N(4B) 76.82(7)
O(3A)-Gd(A)-N(4A) 73.18(7) O(3B)-Gd(B)-N(4B) 127.29(7)
O(2A)-Gd(A)-N(4A) 141.16(7) O(2B)-Gd(B)-N(4B) 139.49(7)
OA-Gd(A)-N(4A) 126.81(7) OB-Gd(B)-N(4B) 130.17(7)
N(5A)-Gd(A)-N(4A) 65.52(7) N(5B)-Gd(B)-N(4B) 66.14(7)
N(3A)-Gd(A)-N(4A) 68.41(7) N(2B)-Gd(B)-N(4B) 104.96(7)
N(1A)-Gd(A)-N(4A) 68.38(7) N(1B)-Gd(B)-N(4B) 69.25(7)
O(1A)-Gd(A)-N(2A) 74.87(7) O(1B)-Gd(B)-N(3B) 143.19(6)
O(3A)-Gd(A)-N(2A) 130.83(7) O(3B)-Gd(B)-N(3B) 65.07(7)
O(2A)-Gd(A)-N(2A) 66.02(7) O(2B)-Gd(B)-N(3B) 132.00(7)
OA-Gd(A)-N(2A) 127.72(7) OB-Gd(B)-N(3B) 128.58(7)
N(5A)-Gd(A)-N(2A) 145.17(8) N(5B)-Gd(B)-N(3B) 80.77(7)
N(3A)-Gd(A)-N(2A) 67.02(7) N(2B)-Gd(B)-N(3B) 67.54(7)
N(1A)-Gd(A)-N(2A) 67.67(7) N(1B)-Gd(B)-N(3B) 103.70(7)
N(4A)-Gd(A)-N(2A) 105.42(7) N(4B)-Gd(B)-N(3B) 66.75(7)
C(10A)-O(1A)-Gd(A) 126.53(17) C(10B)-O(1B)-Gd(B) 126.35(19)
C(12A)-O(2A)-Gd(A) 126.09(18) C(12B)-O(2B)-Gd(B) 124.83(19)
C(14A)-O(3A)-Gd(A) 125.37(19) C(14B)-O(3B)-Gd(B) 126.48(17)
Gd(A)-OA-HA1 121(3) Gd(B)-OB-HB1 114(2)
Gd(A)-OA-HA2 122(3) Gd(B)-OB-HB2 108(3)
HA1-OA-HA2 113(4) HB1-OB-HB2 109(3)
C(9A)-N(1A)-C(1A) 108.9(2) C(9B)-N(1B)-C(8B) 109.3(2)
C(9A)-N(1A)-C(8A) 109.8(2) C(9B)-N(1B)-C(1B) 109.1(2)
C(1A)-N(1A)-C(8A) 109.7(2) C(8B)-N(1B)-C(1B) 109.3(2)
C(9A)-N(1A)-Gd(A) 107.94(16) C(9B)-N(1B)-Gd(B) 106.68(16)
C(1A)-N(1A)-Gd(A) 109.90(16) C(8B)-N(1B)-Gd(B) 110.34(17)
C(8A)-N(1A)-Gd(A) 110.57(16) C(1B)-N(1B)-Gd(B) 112.05(15)
C(11A)-N(2A)-C(3A) 109.6(2) C(11B)-N(2B)-C(3B) 109.7(2)
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C(11A)-N(2A)-C(2A) 110.7(2) C(11B)-N(2B)-C(2B) 110.5(2)
C(3A)-N(2A)-C(2A) 108.0(2) C(3B)-N(2B)-C(2B) 108.6(2)
C(11A)-N(2A)-Gd(A) 104.83(17) C(11B)-N(2B)-Gd(B) 104.44(17)
C(3A)-N(2A)-Gd(A) 112.88(16) C(3B)-N(2B)-Gd(B) 111.54(17)
C(2A)-N(2A)-Gd(A) 110.83(17) C(2B)-N(2B)-Gd(B) 112.09(16)
C(13A)-N(3A)-C(4A) 109.5(2) C(13B)-N(3B)-C(4B) 109.9(2)
C(13A)-N(3A)-C(5A) 109.9(2) C(13B)-N(3B)-C(5B) 109.6(2)
C(4A)-N(3A)-C(5A) 109.0(2) C(4B)-N(3B)-C(5B) 108.8(2)
C(13A)-N(3A)-Gd(A) 105.91(16) C(13B)-N(3B)-Gd(B) 107.34(16)
C(4A)-N(3A)-Gd(A) 112.46(15) C(4B)-N(3B)-Gd(B) 109.89(16)
C(5A)-N(3A)-Gd(A) 110.00(17) C(5B)-N(3B)-Gd(B) 111.35(17)
C(6A)-N(4A)-C(7A) 108.1(2) C(7B)-N(4B)-C(6B) 109.2(2)
C(6A)-N(4A)-C(15A) 106.1(2) C(7B)-N(4B)-C(15B) 110.1(2)
C(7A)-N(4A)-C(15A) 112.6(2) C(6B)-N(4B)-C(15B) 107.3(2)
C(6A)-N(4A)-Gd(A) 110.60(16) C(7B)-N(4B)-Gd(B) 107.71(17)
C(7A)-N(4A)-Gd(A) 111.46(16) C(6B)-N(4B)-Gd(B) 111.28(16)
C(15A)-N(4A)-Gd(A) 107.81(15) C(15B)-N(4B)-Gd(B) 111.20(16)
C(16A)-N(5A)-Gd(A) 119.27(17) C(16B)-N(5B)-Gd(B) 108.28(16)
C(16A)-N(5A)-H(5A1) 107.5 C(16B)-N(5B)-H(5B1) 110.0
Gd(A)-N(5A)-H(5A1) 107.5 Gd(B)-N(5B)-H(5B1) 110.0
C(16A)-N(5A)-H(5A2) 107.5 C(16B)-N(5B)-H(5B2) 110.0
Gd(A)-N(5A)-H(5A2) 107.5 Gd(B)-N(5B)-H(5B2) 110.0
H(5A1)-N(5A)-H(5A2) 107.0 H(5B1)-N(5B)-H(5B2) 108.4
N(1A)-C(1A)-C(2A) 112.5(2) N(1B)-C(1B)-C(2B) 112.0(2)
N(1A)-C(1A)-H(1A1) 109.1 N(1B)-C(1B)-H(1B1) 109.2
C(2A)-C(1A)-H(1A1) 109.1 C(2B)-C(1B)-H(1B1) 109.2
N(1A)-C(1A)-H(1A2) 109.1 N(1B)-C(1B)-H(1B2) 109.2
C(2A)-C(1A)-H(1A2) 109.1 C(2B)-C(1B)-H(1B2) 109.2
H(1A1)-C(1A)-H(1A2) 107.8 H(1B1)-C(1B)-H(1B2) 107.9
N(2A)-C(2A)-C(1A) 110.6(2) N(2B)-C(2B)-C(1B) 113.7(2)
N(2A)-C(2A)-H(2A1) 109.5 N(2B)-C(2B)-H(2B1) 108.8
C(1A)-C(2A)-H(2A1) 109.5 C(1B)-C(2B)-H(2B1) 108.8
N(2A)-C(2A)-H(2A2) 109.5 N(2B)-C(2B)-H(2B2) 108.8
C(1A)-C(2A)-H(2A2) 109.5 C(1B)-C(2B)-H(2B2) 108.8
H(2A1)-C(2A)-H(2A2) 108.1 H(2B1)-C(2B)-H(2B2) 107.7
N(2A)-C(3A)-C(4A) 112.9(2) N(2B)-C(3B)-C(4B) 111.4(2)
N(2A)-C(3A)-H(3A1) 109.0 N(2B)-C(3B)-H(3B1) 109.3
C(4A)-C(3A)-H(3A1) 109.0 C(4B)-C(3B)-H(3B1) 109.3
N(2A)-C(3A)-H(3A2) 109.0 N(2B)-C(3B)-H(3B2) 109.3
C(4A)-C(3A)-H(3A2) 109.0 C(4B)-C(3B)-H(3B2) 109.3
H(3A1)-C(3A)-H(3A2) 107.8 H(3B1)-C(3B)-H(3B2) 108.0
N(3A)-C(4A)-C(3A) 112.1(2) N(3B)-C(4B)-C(3B) 112.3(2)
N(3A)-C(4A)-H(4A1) 109.2 N(3B)-C(4B)-H(4B1) 109.1
C(3A)-C(4A)-H(4A1) 109.2 C(3B)-C(4B)-H(4B1) 109.1
N(3A)-C(4A)-H(4A2) 109.2 N(3B)-C(4B)-H(4B2) 109.1
C(3A)-C(4A)-H(4A2) 109.2 C(3B)-C(4B)-H(4B2) 109.1
H(4A1)-C(4A)-H(4A2) 107.9 H(4B1)-C(4B)-H(4B2) 107.9
N(3A)-C(5A)-C(6A) 113.7(2) N(3B)-C(5B)-C(6B) 111.3(2)
N(3A)-C(5A)-H(5A3) 108.8 N(3B)-C(5B)-H(5B3) 109.4
C(6A)-C(5A)-H(5A3) 108.8 C(6B)-C(5B)-H(5B3) 109.4
N(3A)-C(5A)-H(5A4) 108.8 N(3B)-C(5B)-H(5B4) 109.4
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C(6A)-C(5A)-H(5A4) 108.8 C(6B)-C(5B)-H(5B4) 109.4
H(5A3)-C(5A)-H(5A4) 107.7 H(5B3)-C(5B)-H(5B4) 108.0
N(4A)-C(6A)-C(5A) 112.2(2) N(4B)-C(6B)-C(5B) 112.6(2)
N(4A)-C(6A)-H(6A1) 109.2 N(4B)-C(6B)-H(6B1) 109.1
C(5A)-C(6A)-H(6A1) 109.2 C(5B)-C(6B)-H(6B1) 109.1
N(4A)-C(6A)-H(6A2) 109.2 N(4B)-C(6B)-H(6B2) 109.1
C(5A)-C(6A)-H(6A2) 109.2 C(5B)-C(6B)-H(6B2) 109.1
H(6A1)-C(6A)-H(6A2) 107.9 H(6B1)-C(6B)-H(6B2) 107.8
N(4A)-C(7A)-C(8A) 115.3(2) N(4B)-C(7B)-C(8B) 112.3(2)
N(4A)-C(7A)-H(7A1) 108.5 N(4B)-C(7B)-H(7B1) 109.2
C(8A)-C(7A)-H(7A1) 108.5 C(8B)-C(7B)-H(7B1) 109.2
N(4A)-C(7A)-H(7A2) 108.5 N(4B)-C(7B)-H(7B2) 109.2
C(8A)-C(7A)-H(7A2) 108.5 C(8B)-C(7B)-H(7B2) 109.2
H(7A1)-C(7A)-H(7A2) 107.5 H(7B1)-C(7B)-H(7B2) 107.9
N(1A)-C(8A)-C(7A) 112.7(2) N(1B)-C(8B)-C(7B) 113.4(2)
N(1A)-C(8A)-H(8A1) 109.1 N(1B)-C(8B)-H(8B1) 108.9
C(7A)-C(8A)-H(8A1) 109.1 C(7B)-C(8B)-H(8B1) 108.9
N(1A)-C(8A)-H(8A2) 109.1 N(1B)-C(8B)-H(8B2) 108.9
C(7A)-C(8A)-H(8A2) 109.1 C(7B)-C(8B)-H(8B2) 108.9
H(8A1)-C(8A)-H(8A2) 107.8 H(8B1)-C(8B)-H(8B2) 107.7
N(1A)-C(9A)-C(10A) 114.4(2) N(1B)-C(9B)-C(10B) 112.2(2)
N(1A)-C(9A)-H(9A1) 108.7 N(1B)-C(9B)-H(9B1) 109.2
C(10A)-C(9A)-H(9A1) 108.7 C(10B)-C(9B)-H(9B1) 109.2
N(1A)-C(9A)-H(9A2) 108.7 N(1B)-C(9B)-H(9B2) 109.2
C(10A)-C(9A)-H(9A2) 108.7 C(10B)-C(9B)-H(9B2) 109.2
H(9A1)-C(9A)-H(9A2) 107.6 H(9B1)-C(9B)-H(9B2) 107.9
O(4A)-C(10A)-O(1A) 124.1(3) O(4B)-C(10B)-O(1B) 124.2(3)
O(4A)-C(10A)-C(9A) 117.6(3) O(4B)-C(10B)-C(9B) 119.3(2)
O(1A)-C(10A)-C(9A) 118.3(2) O(1B)-C(10B)-C(9B) 116.5(2)
N(2A)-C(11A)-C(12A) 111.8(2) N(2B)-C(11B)-C(12B) 112.7(2)
N(2A)-C(11A)-H(11A) 109.2 N(2B)-C(11B)-H(11C) 109.0
C(12A)-C(11A)-H(11A) 109.2 C(12B)-C(11B)-H(11C) 109.0
N(2A)-C(11A)-H(11B) 109.2 N(2B)-C(11B)-H(11D) 109.0
C(12A)-C(11A)-H(11B) 109.2 C(12B)-C(11B)-H(11D) 109.0
H(11A)-C(11A)-H(11B) 107.9 H(11C)-C(11B)-H(11D) 107.8
O(5A)-C(12A)-O(2A) 125.2(3) O(5B)-C(12B)-O(2B) 125.0(3)
O(5A)-C(12A)-C(11A) 119.4(3) O(5B)-C(12B)-C(11B) 118.7(3)
O(2A)-C(12A)-C(11A) 115.4(3) O(2B)-C(12B)-C(11B) 116.3(3)
N(3A)-C(13A)-C(14A) 112.7(2) N(3B)-C(13B)-C(14B) 113.9(2)
N(3A)-C(13A)-H(13A) 109.0 N(3B)-C(13B)-H(13C) 108.8
C(14A)-C(13A)-H(13A) 109.0 C(14B)-C(13B)-H(13C) 108.8
N(3A)-C(13A)-H(13B) 109.0 N(3B)-C(13B)-H(13D) 108.8
C(14A)-C(13A)-H(13B) 109.0 C(14B)-C(13B)-H(13D) 108.8
H(13A)-C(13A)-H(13B) 107.8 H(13C)-C(13B)-H(13D) 107.7
O(6A)-C(14A)-O(3A) 124.0(3) O(6B)-C(14B)-O(3B) 124.7(3)
O(6A)-C(14A)-C(13A) 119.4(2) O(6B)-C(14B)-C(13B) 116.8(3)
O(3A)-C(14A)-C(13A) 116.5(2) O(3B)-C(14B)-C(13B) 118.4(2)
C(16A)-C(15A)-N(4A) 114.1(2) C(16B)-C(15B)-N(4B) 114.7(2)
C(16A)-C(15A)-H(15A) 108.7 C(16B)-C(15B)-H(15C) 108.6
N(4A)-C(15A)-H(15A) 108.7 N(4B)-C(15B)-H(15C) 108.6
C(16A)-C(15A)-H(15B) 108.7 C(16B)-C(15B)-H(15D) 108.6
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N(4A)-C(15A)-H(15B) 108.7 N(4B)-C(15B)-H(15D) 108.6
H(15A)-C(15A)-H(15B) 107.6 H(15C)-C(15B)-H(15D) 107.6
N(5A)-C(16A)-C(15A) 110.6(2) N(5B)-C(16B)-C(15B) 109.7(2)
N(5A)-C(16A)-H(16A) 109.5 N(5B)-C(16B)-H(16C) 109.7
C(15A)-C(16A)-H(16A) 109.5 C(15B)-C(16B)-H(16C) 109.7
N(5A)-C(16A)-H(16B) 109.5 N(5B)-C(16B)-H(16D) 109.7
C(15A)-C(16A)-H(16B) 109.5 C(15B)-C(16B)-H(16D) 109.7
H(16A)-C(16A)-H(16B) 108.1 H(16C)-C(16B)-H(16D) 108.2
H(1E)-O(1)-H(1F) 108(3) H(7E)-O(7)-H(7F) 104(3)
H(2E)-O(2)-H(2F) 101(3) H(8E)-O(8)-H(8F) 111(4)
H(3E)-O(3)-H(3F) 101(3) H(9E)-O(9)-H(9F) 116(3)
H(4E)-O(4)-H(4F) 113(3) H(10E)-O(10)-H(10F) 101(3)
H(5E)-O(5)-H(5F) 106(4) H(11E)-O(11)-H(11F) 110(2)
H(6E)-O(6)-H(6F) 104(4) H(12E)-O(12)-H(12F) 103(3)
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Table A.2.5. Anisotropic displacement parameters (Å2x 104 ) for AEDO3A-Gd.
The anisotropic displacement factor exponent takes the form: The anisotropic
displacement factor exponent takes the form:
-2π2[ h2 a*2U11 + … + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
O(1A) 177(12) 115(9) 125(11) -51(8) -33(9) 4(8)
O(2A) 122(12) 183(10) 119(11) -50(8) -35(9) 21(8)
O(3A) 137(12) 85(9) 118(11) -32(8) -19(9) 11(8)
O(4A) 159(12) 100(9) 206(12) -74(8) -24(9) 0(8)
O(5A) 184(13) 274(11) 272(13) -105(10) -140(10) 80(10)
O(6A) 177(12) 136(9) 130(11) -70(8) -9(9) 14(8)
O(A) 158(13) 99(9) 145(12) -34(9) -9(10) 10(9)
N(1A) 106(13) 111(11) 114(13) -34(10) -17(10) -32(9)
N(2A) 131(14) 110(11) 111(13) -39(10) -32(11) 8(10)
N(3A) 116(14) 101(11) 114(13) -42(10) -11(11) -10(10)
N(4A) 126(13) 142(11) 117(13) -14(10) -32(10) 24(10)
N(5A) 143(14) 150(11) 137(14) -40(10) -41(11) -3(10)
C(1A) 146(16) 215(14) 121(16) -99(12) -12(13) -36(12)
C(2A) 152(17) 147(13) 164(16) -99(12) 30(13) -24(12)
C(3A) 122(17) 147(14) 153(17) -74(12) -2(14) -17(12)
C(4A) 98(16) 139(13) 150(17) -57(12) -17(13) -25(12)
C(5A) 177(17) 90(12) 136(16) -20(12) -18(13) -14(11)
C(6A) 249(18) 78(12) 120(15) -1(11) -68(13) 46(12)
C(7A) 184(17) 141(13) 137(16) 1(12) -76(13) -6(12)
C(8A) 199(17) 181(14) 88(15) -15(12) -85(13) 10(12)
C(9A) 144(16) 145(13) 138(16) -83(12) -46(13) 5(12)
C(10A) 53(15) 117(13) 176(16) -87(12) 5(12) -13(11)
C(11A) 118(16) 158(13) 174(16) -69(12) -50(13) 34(12)
C(12A) 121(16) 102(13) 168(16) -17(12) -61(13) -5(11)
C(13A) 137(16) 115(13) 114(16) -62(11) -25(13) -22(11)
C(14A) 163(17) 78(12) 75(15) -16(11) -57(13) 15(11)
C(15A) 141(15) 178(14) 166(16) -36(12) -37(13) 47(12)
C(16A) 137(15) 190(14) 176(16) -70(13) -36(13) 43(12)
Gd(B) 80(1) 85(1) 81(1) -31(1) -25(1) -2(1)
O(1B) 110(11) 103(9) 111(11) -37(8) -7(9) -17(8)
O(2B) 106(11) 141(9) 138(11) -46(8) -47(9) 7(8)
O(3B) 172(12) 118(9) 119(11) -54(8) -31(9) -4(8)
O(4B) 173(12) 124(9) 164(12) -72(9) -34(10) 32(8)
O(5B) 153(12) 199(10) 238(12) -88(9) -114(10) 40(9)
O(6B) 183(12) 125(9) 201(12) -96(9) -40(9) -16(8)
O(B) 126(13) 137(10) 129(12) -45(9) -43(9) 31(8)
N(1B) 96(14) 122(11) 98(13) -48(10) -4(11) -4(10)
N(2B) 86(13) 125(11) 128(13) -66(10) -13(11) -14(10)
N(3B) 130(13) 157(11) 82(12) -32(10) -32(10) -33(10)
N(4B) 127(14) 141(11) 150(14) 4(10) -35(11) -6(10)
N(5B) 150(14) 125(11) 99(13) -28(10) -19(11) -21(10)
C(1B) 112(16) 124(13) 139(16) -51(12) 0(13) -21(12)
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Table A.2.5. Anisotropic displacement parameters (Å2x 104 ) for AEDO3A-Gd.
The anisotropic displacement factor exponent takes the form: The anisotropic
displacement factor exponent takes the form:
-2π2[ h2 a*2U11 + … + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
C(2B) 112(17) 134(13) 147(17) -30(12) 0(13) -51(12)
C(3B) 138(16) 173(14) 175(16) -104(12) 30(13) -18(12)
C(4B) 171(17) 231(15) 95(15) -71(12) 42(13) -72(13)
C(5B) 199(17) 196(14) 100(15) -11(12) -58(13) -69(12)
C(6B) 267(19) 194(14) 79(15) 4(12) -78(13) -29(13)
C(7B) 231(18) 156(14) 103(15) -20(12) -42(13) 73(13)
C(8B) 231(18) 92(13) 127(16) -30(12) -43(14) 2(12)
C(9B) 163(17) 107(13) 147(16) -66(12) -35(14) -9(12)
C(10B) 142(17) 126(13) 73(15) -16(11) -49(13) 31(12)
C(11B) 104(16) 138(13) 211(17) -62(12) -51(13) 37(12)
C(12B) 171(18) 70(12) 152(16) -18(11) -53(13) 10(12)
C(13B) 146(16) 148(13) 145(16) -83(12) -25(13) -41(12)
C(14B) 64(15) 174(14) 126(15) -59(12) -3(12) 10(11)
C(15B) 166(16) 238(16) 226(17) -34(14) -89(14) 76(13)
C(16B) 118(15) 215(15) 271(18) -99(14) -27(14) 8(12)
O(1) 217(13) 159(11) 226(13) -81(10) -63(11) 12(9)
O(2) 139(13) 171(11) 220(13) -105(9) -1(10) 1(9)
O(3) 285(16) 254(12) 345(15) -165(12) -170(12) 63(11)
O(4) 245(13) 106(10) 172(12) -36(9) -28(11) -5(9)
O(5) 277(15) 192(11) 301(15) -131(10) -214(12) 100(10)
O(6) 159(13) 151(10) 233(13) -8(10) -89(11) 18(10)
O(7) 229(15) 210(11) 362(15) -156(11) -144(12) 52(11)
O(8) 204(13) 174(11) 176(12) -62(10) -36(11) -28(9)
O(9) 170(13) 135(10) 249(14) -83(10) -34(10) -7(9)
O(10) 240(14) 185(11) 290(14) -166(10) 3(11) -16(10)
O(11) 217(13) 239(11) 179(13) -84(10) -49(10) 21(10)
O(12) 209(14) 183(11) 240(13) -86(10) -9(11) -15(9)
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Table A.2.6. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103)
for AEDO3A-Gd.
x y z Uiso
H(A1) 9370(30) 4450(20) 2860(20) 17
H(A2) 9860(30) 3790(20) 2720(20) 17
H(5A1) 11131 3404 3857 17
H(5A2) 10723 3689 4603 17
H(1A1) 6475 3189 6921 18
H(1A2) 6396 2301 6667 18
H(2A1) 4649 3301 6312 18
H(2A2) 5743 4105 5691 18
H(3A1) 3887 2263 5681 17
H(3A2) 5038 1822 6166 17
H(4A1) 4745 971 5346 15
H(4A2) 4958 1883 4513 15
H(5A3) 6667 120 5686 17
H(5A4) 6582 866 6134 17
H(6A1) 8657 179 6100 19
H(6A2) 8958 506 5088 19
H(7A1) 9528 1250 6667 19
H(7A2) 7963 1314 6690 19
H(8A1) 8654 2542 6988 19
H(8A2) 9828 2849 6142 19
H(9A1) 9302 4214 5756 16
H(9A2) 7805 4358 6202 16
H(11A) 5266 4356 4473 17
H(11B) 4005 3642 4769 17
H(13A) 6528 1463 3719 14
H(13B) 6836 467 4327 14
H(15A) 10980 1044 5549 20
H(15B) 10694 1378 4622 20
H(16A) 11452 2512 5429 20
H(16B) 12266 2402 4565 20
H(B1) 320(30) 6210(20) 12360(20) 16
H(B2) 1270(30) 5700(20) 12270(20) 16
H(5B1) -656 6381 10274 15
H(5B2) -990 6224 11199 15
H(1B1) 5003 8226 10436 15
H(1B2) 5133 9081 9564 15
H(2B1) 4882 8105 8850 17
H(2B2) 6077 7762 9320 17
H(3B1) 4375 5754 9511 19
H(3B2) 5485 6531 8862 19
H(4B1) 3782 7464 8340 21
H(4B2) 3745 6494 8213 21
H(5B3) 369 6975 8798 21
H(5B4) 1619 7225 7994 21
H(6B1) 2310 8447 8332 22
H(6B2) 824 8581 8178 22
H(7B1) 798 9273 9912 21
H(7B2) 1107 9657 8898 21
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Table A.2.6. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103)
for AEDO3A-Gd.
H(8B1) 3323 9127 8841 18
H(8B2) 3061 9859 9310 18
H(9B1) 3012 9559 10616 16
H(9B2) 3409 8596 11233 16
H(11C) 6027 6430 10357 18
H(11D) 4827 5664 10685 18
H(13C) 2274 5412 8921 17
H(13D) 791 5607 9346 17
H(15C) -996 8778 9557 26
H(15D) -910 7945 9213 26
H(16C) -1167 7788 10924 24
H(16D) -2225 7405 10558 24
H(1E) 3090(30) 170(20) 1890(20) 23
H(1F) 1890(30) 170(20) 1670(20) 23
H(2E) 1010(30) 1340(20) 2900(20) 21
H(2F) 2010(30) 1200(20) 2370(20) 21
H(3E) 4050(40) 2350(20) 3120(20) 32
H(3F) 3300(40) 1820(20) 3050(20) 32
H(4E) 1610(30) 3650(20) 1650(20) 22
H(4F) 1490(30) 2880(20) 2260(20) 22
H(5E) 3110(30) 4500(20) 2910(20) 27
H(5F) 2480(40) 4390(20) 2470(20) 27
H(6E) 6710(30) 5580(20) 2240(20) 23
H(6F) 7290(30) 4930(20) 2550(20) 23
H(7E) 5910(30) 7750(20) 1830(20) 29
H(7F) 6710(30) 8260(20) 1910(20) 29
H(8E) 8470(30) 6280(20) 3500(20) 22
H(8F) 8100(30) 6210(20) 2900(20) 22
H(9E) 8960(30) 8630(20) 2140(20) 22
H(9F) 8230(30) 7790(20) 2680(20) 22
H(10E) 7660(30) 9230(20) 3090(20) 27
H(10F) 8090(30) 9890(20) 3280(20) 27
H(11E) 5020(30) 8990(20) 7027(19) 25
H(11F) 3830(30) 9690(20) 7090(20) 25
H(12E) 4760(30) 9710(20) 2370(20) 26
H(12F) 4860(30) 9020(20) 2130(20) 26
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Table A.2.7. Hydrogen bonds for AEDO3A-Gd [Å and °].
D-H…A d(D-H) d(H…A) d(D…A) <(DHA)
N(5A)-H(5A1)…O(5)#1 0.92 2.46 3.248(4) 144.4
N(5A)-H(5A2)…O(4A)#2 0.92 2.16 2.984(3) 148.4
N(5B)-H(5B1)…O(6B)#3 0.92 2.20 3.052(3) 153.7
N(5B)-H(5B2)…O(6)#4 0.92 2.25 3.133(3) 160.1
O(1)-H(1E)…O(12)#5 0.89(3) 1.82(3) 2.704(3) 175(3)
O(1)-H(1F)…O(4B)#6 0.80(3) 1.99(3) 2.781(3) 170(3)
O(2)-H(2E)…O(6A)#7 0.81(3) 2.01(3) 2.812(3) 170(3)
O(2)-H(2E)…O(3A)#7 0.81(3) 2.55(3) 3.126(3) 129(3)
O(2)-H(2F)…O(1) 0.84(3) 1.86(3) 2.690(3) 173(3)
O(3)-H(3E)…O(5A) 0.75(3) 2.22(3) 2.904(3) 153(4)
O(3)-H(3F)…O(2) 0.81(3) 1.99(3) 2.796(3) 171(3)
O(4)-H(4E)…O(6B)#8 0.74(3) 1.99(3) 2.725(3) 175(4)
O(4)-H(4E)…O(3B)#8 0.74(3) 2.62(3) 3.128(3) 128(3)
O(4)-H(4F)…O(2) 0.80(3) 1.94(3) 2.723(3) 166(3)
O(5)-H(5E)…O(5A) 0.75(3) 2.06(3) 2.767(3) 157(3)
O(5)-H(5F)…O(4) 0.71(3) 2.14(3) 2.803(3) 157(4)
O(6)-H(6E)…O(5B)#8 0.77(3) 2.01(3) 2.734(3) 158(3)
O(6)-H(6F)…O(2A) 0.71(3) 2.49(3) 3.193(3) 168(4)
O(7)-H(7E)…O(5B)#8 0.78(3) 2.09(3) 2.859(3) 168(3)
O(7)-H(7F)…O(9) 0.79(3) 2.02(3) 2.799(3) 172(4)
O(8)-H(8E)…O(4A) 0.75(3) 2.02(3) 2.765(3) 176(4)
O(8)-H(8E)…O(1A) 0.75(3) 2.62(3) 3.090(3) 122(3)
O(8)-H(8F)…O(6) 0.73(3) 2.07(3) 2.785(3) 165(4)
O(9)-H(9E)…O(4B)#9 0.86(3) 1.93(3) 2.776(3) 167(3)
O(9)-H(9E)…O(1B)#9 0.86(3) 2.61(3) 3.179(3) 125(2)
O(9)-H(9F)…O(8) 0.81(3) 1.93(3) 2.735(3) 170(3)
O(10)-H(10E)…O(9) 0.75(3) 2.02(3) 2.768(3) 170(4)
O(10)-H(10F)…O(6A)#10 0.94(3) 1.84(3) 2.751(3) 161(3)
O(11)-H(11E)…O(3)#11 0.99(3) 1.80(3) 2.751(3) 159(3)
O(11)-H(11F)…O(10)#12 0.98(3) 1.73(3) 2.706(3) 171(3)
O(12)-H(12E)…O(11)#12 0.75(3) 2.00(3) 2.731(3) 166(4)
O(12)-H(12F)…O(7) 0.88(3) 1.85(3) 2.727(3) 179(3)














Crystal Structure Analysis of Asp-AEDO3A-Gd
Table A.3.1. Crystal data
Table A.3.2. Atomic Coordinates
Table A.3.3. Full bond distances
Table A.3.4. Full bond angles
Table A.3.5. Anisotropic displacement parameters
Table A.3.6. Hydrogen atomic coordinates
Table A.3.7. Hydrogen bond distances and angles
Crystallographic data have been deposited with the CCDC as supplementary
publication CCDC 204982. These data can be obtained free of charge via
http://www.ccdc.cam.ac.uk/ conts/retrieving.html (or from CCDC, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: +44 1223 335033; or deposit@ccdc.cam.ac.uk). Structure
factors are available from the author via email: xray@caltech.edu.
Table A.2.1. Crystal data and structure refinement for Asp-AEDO3A-Gd.








Type of diffractometer Bruker SMART 1000
Wavelength 0.71073 Å Mo Kα
Data Collection Temperature 98(2) K
θ range for 15223 reflections used in
lattice determination
2.20 to 46.27°
Unit cell dimensions a = 9.0229(3) Å
b = 18.2905(6) Å β = 95.2850(10)°





Density (calculated) 1.735 Mg/m3
F(000) 810
Data collection program Bruker SMART v5.054
θ range for data collection 2.20 to 46.17°
Completeness to θ = 28.19° 99.0 %
Index ranges -18 ≤ h ≤ 18, -36 ≤ k ≤ 35, -18 ≤ l ≤ 18
Data collection scan type ω scans at 7 φ settings each for 2 settings of 2θ
Data reduction program Bruker SAINT v6.022
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Table A.2.1. Crystal data and structure refinement for Asp-AEDO3A-Gd.
Reflections collected 88027
Independent reflections 25434 [Rint = 0.0419]
Absorption coefficient 2.255 mm-1
Absorption correction SADABS
Max. and min. transmission 1.0000 and 0.7853
Structure solution and Refinement
Structure solution program SHELXS-97 (Sheldrick, 1990)
Primary solution method Direct methods
Secondary solution method Difference Fourier map
Hydrogen placement Difference Fourier map
Structure refinement program SHELXL-97 (Sheldrick, 1997)
Refinement method Full matrix least-squares on F2
Data / restraints / parameters 25434 / 1 / 586
Treatment of hydrogen atoms Unrestrained
Goodness-of-fit on F2 1.136
Final R indices [I>2σ(I), 23032
reflections]
R1 = 0.0236, ωR2 = 0.0407
R indices (all data) R1 = 0.0281, ωR2 = 0.0412
Type of weighting scheme used Sigma
Weighting scheme used ω=1/σ2(Fo2)
Max shift/error 0.001
Average shift/error 0.000
Absolute structure parameter 0.001(3)
Largest diff. peak and hole 2.470 and -1.470 e.Å-3
Special Refinement Details
The top twenty peaks in the difference Fourier map were all within one angstrom of the metal center and arise
presumably incomplete absorption correction. All non-hydrogen atoms were refined anisotropically and all
hydrogen atoms were refined isotropically without any restraints whatsoever.
Refinement of F2 against ALL reflections. The weighted R-factor (ωR) and goodness of fit (S) are based on F2,
conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold expression of F2 >
2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement.
R-factors based on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data
will be even larger. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the
full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances,
angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by
crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s.
planes.
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Table A.3.2. Atomic coordinates ( x 104 ) and equivalent isotropic displacement parameters
(Å2x 103) for Asp-AEDO3A-Gd. Ueq is defined as the trace of the orthogonalized Uij tensor.
x y z Ueq
Gd(1) 1827(1) 2498(1) 882(1) 5(1)
O(1) 4165(1) 2798(1) -110(1) 9(1)
O(2) 4989(1) 3590(1) -1696(1) 11(1)
O(3) 919(1) 3047(1) -1379(1) 10(1)
O(4) -979(1) 3467(1) -2873(1) 12(1)
O(5) -280(1) 1663(1) 452(1) 9(1)
O(6) -1848(1) 829(1) 1218(1) 14(1)
O(7) 3945(1) 227(1) 1035(1) 13(1)
O(8) 2917(1) 470(1) -4456(1) 13(1)
O(9) 775(1) 342(1) -3447(1) 13(1)
N(1) 2880(1) 3833(1) 1413(1) 8(1)
N(2) -328(1) 3506(1) 976(1) 8(1)
N(3) 89(1) 2284(1) 3060(1) 9(1)
N(4) 3287(1) 2593(1) 3485(1) 9(1)
N(5) 3337(1) 1429(1) 1485(1) 8(1)
N(6) 2197(1) 1646(1) -1196(1) 8(1)
C(1) 3501(1) 4062(1) 70(1) 10(1)
C(2) 4292(1) 3436(1) -633(1) 8(1)
C(3) 1733(1) 4367(1) 1786(1) 10(1)
C(4) 287(1) 4259(1) 844(1) 10(1)
C(5) 4102(1) 3805(1) 2607(1) 11(1)
C(6) 3683(1) 3363(1) 3889(1) 10(1)
C(7) -1326(1) 3358(1) -345(1) 11(1)
C(8) -395(1) 3287(1) -1641(1) 9(1)
C(9) -1123(1) 3468(1) 2300(1) 10(1)
C(10) -1344(1) 2687(1) 2796(1) 10(1)
C(11) -262(1) 1493(1) 2990(1) 10(1)
C(12) -853(1) 1301(1) 1444(1) 9(1)
C(13) 831(1) 2489(1) 4496(1) 10(1)
C(14) 2460(1) 2265(1) 4643(1) 11(1)
C(15) 4680(1) 2171(1) 3353(1) 10(1)
C(16) 4373(1) 1402(1) 2794(1) 10(1)
C(17) 3292(1) 826(1) 704(1) 8(1)
C(18) 2362(1) 872(1) -762(1) 8(1)
C(19) 3049(1) 401(1) -1884(1) 9(1)
C(20) 2175(1) 411(1) -3371(1) 9(1)
Li 6726(3) 1532(1) 7228(3) 14(1)
O(11) 5904(1) 769(1) 5946(1) 13(1)
O(12) 6014(1) 1551(1) 9163(1) 16(1)
O(13) 6426(1) 2557(1) 6715(1) 14(1)
O(14) 8839(1) 1363(1) 7561(1) 14(1)
Li(2) 4823(2) -413(1) 2484(2) 12(1)
O(20) 6788(1) 3(1) 3306(1) 11(1)
O(21) 3464(1) -680(1) 3889(1) 14(1)
O(22) -692(1) -623(1) -5409(1) 13(1)
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Table A.2.3. Bond lengths [Å] for  Asp-AEDO3A-Gd.
Gd(1)-O(3) 2.4023(8) C(1)-H(1B) 0.865(17)
Gd(1)-N(5) 2.4187(9) C(3)-C(4) 1.5150(17)
Gd(1)-O(1) 2.4406(8) C(3)-H(3A) 0.952(15)
Gd(1)-O(5) 2.4422(8) C(3)-H(3B) 0.938(19)
Gd(1)-N(6) 2.5261(10) C(4)-H(4A) 0.913(18)
Gd(1)-N(4) 2.6479(9) C(4)-H(4B) 0.894(17)
Gd(1)-N(1) 2.6497(9) C(5)-C(6) 1.5146(18)
Gd(1)-N(2) 2.6868(10) C(5)-H(5A) 0.952(19)
Gd(1)-N(3) 2.6989(10) C(5)-H(5B) 0.965(17)
O(1)-C(2) 1.2739(13) C(6)-H(6C) 0.982(18)
O(2)-C(2) 1.2505(14) C(6)-H(6D) 0.926(18)
O(2)-Li(2)#1 1.977(2) C(7)-C(8) 1.5346(16)
O(3)-C(8) 1.2668(13) C(7)-H(7A) 0.980(18)
O(4)-C(8) 1.2579(15) C(7)-H(7B) 0.979(18)
O(5)-C(12) 1.2813(14) C(9)-C(10) 1.5192(16)
O(6)-C(12) 1.2492(14) C(9)-H(9A) 0.957(16)
O(7)-C(17) 1.2679(14) C(9)-H(9B) 0.980(18)
O(7)-Li(2) 1.900(2) C(10)-H(10A) 1.021(16)
O(8)-C(20) 1.2639(14) C(10)-H(10B) 0.900(18)
O(9)-C(20) 1.2649(14) C(11)-C(12) 1.5256(17)
N(1)-C(1) 1.4737(15) C(11)-H(11A) 0.924(19)
N(1)-C(3) 1.4863(14) C(11)-H(11B) 0.870(17)
N(1)-C(5) 1.4904(16) C(13)-C(14) 1.5202(16)
N(2)-C(7) 1.4782(15) C(13)-H(13A) 0.940(19)
N(2)-C(9) 1.4807(15) C(13)-H(13B) 0.905(18)
N(2)-C(4) 1.4950(15) C(14)-H(14A) 0.923(15)
N(3)-C(11) 1.4808(15) C(14)-H(14B) 0.971(16)
N(3)-C(13) 1.4838(14) C(15)-C(16) 1.5157(17)
N(3)-C(10) 1.4885(15) C(15)-H(15A) 0.942(17)
N(4)-C(15) 1.4896(14) C(15)-H(15B) 0.986(17)
N(4)-C(14) 1.4896(15) C(16)-H(16A) 1.067(17)
N(4)-C(6) 1.4931(14) C(16)-H(16B) 0.940(19)
N(5)-C(17) 1.3184(14) C(17)-C(18) 1.5344(16)
N(5)-C(16) 1.4638(15) C(18)-C(19) 1.5261(16)
N(6)-C(18) 1.4745(14) C(18)-H(18) 1.020(15)
N(6)-H(6A) 0.882(19) C(19)-C(20) 1.5255(16)
N(6)-H(6B) 0.746(18) C(19)-H(19A) 0.941(19)
C(1)-C(2) 1.5264(16) C(19)-H(19B) 0.946(18)
C(1)-H(1A) 0.956(19)
Li-O(14) 1.928(3) O(14)-H(14C) 0.75(2)
Li-O(11) 1.936(3) O(14)-H(14D) 0.54(3)
Li-O(13) 1.947(3) Li(2)-O(21) 1.933(3)
Li-O(12) 1.963(3) Li(2)-O(2)#2 1.977(2)
Li-H(13C) 2.33(2) Li(2)-O(20) 2.014(2)
Li-H(14D) 2.07(3) Li(2)-H(21D) 2.29(2)
O(11)-H(11C) 0.70(2) O(20)-H(20C) 0.76(2)
O(11)-H(11D) 0.74(2) O(20)-H(20D) 0.76(2)
O(12)-H(12C) 0.85(2) O(21)-H(21C) 0.81(2)
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Table A.2.3. Bond lengths [Å] for  Asp-AEDO3A-Gd.
O(12)-H(12D) 0.79(2) O(21)-H(21D) 0.75(2)
O(13)-H(13C) 0.73(2) O(22)-H(22A) 0.70(2)
O(13)-H(13D) 0.75(2) O(22)-H(22B) 0.79(2)
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Table A.2.4. Bond Angles [°] for Asp-AEDO3A-Gd.
O(3)-Gd(1)-N(5) 132.83(3) C(5)-N(1)-Gd(1) 109.53(7)
O(3)-Gd(1)-O(1) 79.24(3) C(7)-N(2)-C(9) 112.01(9)
N(5)-Gd(1)-O(1) 77.36(3) C(7)-N(2)-C(4) 107.65(9)
O(3)-Gd(1)-O(5) 85.46(3) C(9)-N(2)-C(4) 108.88(9)
N(5)-Gd(1)-O(5) 86.89(3) C(7)-N(2)-Gd(1) 103.61(7)
O(1)-Gd(1)-O(5) 139.95(3) C(9)-N(2)-Gd(1) 113.69(7)
O(3)-Gd(1)-N(6) 69.47(3) C(4)-N(2)-Gd(1) 110.79(7)
N(5)-Gd(1)-N(6) 64.32(3) C(11)-N(3)-C(13) 111.27(12)
O(1)-Gd(1)-N(6) 70.78(3) C(11)-N(3)-C(10) 107.35(9)
O(5)-Gd(1)-N(6) 69.20(3) C(13)-N(3)-C(10) 109.66(10)
O(3)-Gd(1)-N(4) 150.51(3) C(11)-N(3)-Gd(1) 104.21(7)
N(5)-Gd(1)-N(4) 67.67(3) C(13)-N(3)-Gd(1) 112.98(6)
O(1)-Gd(1)-N(4) 87.43(3) C(10)-N(3)-Gd(1) 111.13(7)
O(5)-Gd(1)-N(4) 120.29(3) C(15)-N(4)-C(14) 109.43(9)
N(6)-Gd(1)-N(4) 130.36(3) C(15)-N(4)-C(6) 109.01(9)
O(3)-Gd(1)-N(1) 82.20(3) C(14)-N(4)-C(6) 108.85(9)
N(5)-Gd(1)-N(1) 121.17(3) C(15)-N(4)-Gd(1) 104.10(6)
O(1)-Gd(1)-N(1) 63.62(3) C(14)-N(4)-Gd(1) 113.05(7)
O(5)-Gd(1)-N(1) 150.08(3) C(6)-N(4)-Gd(1) 112.23(7)
N(6)-Gd(1)-N(1) 129.81(3) C(17)-N(5)-C(16) 114.38(9)
N(4)-Gd(1)-N(1) 68.31(3) C(17)-N(5)-Gd(1) 124.15(7)
O(3)-Gd(1)-N(2) 63.34(3) C(16)-N(5)-Gd(1) 121.46(7)
N(5)-Gd(1)-N(2) 160.22(3) C(18)-N(6)-Gd(1) 113.60(7)
O(1)-Gd(1)-N(2) 120.74(3) C(18)-N(6)-H(6A) 114.0(12)
O(5)-Gd(1)-N(2) 83.07(3) Gd(1)-N(6)-H(6A) 110.3(12)
N(6)-Gd(1)-N(2) 126.50(3) C(18)-N(6)-H(6B) 109.2(14)
N(4)-Gd(1)-N(2) 103.07(3) Gd(1)-N(6)-H(6B) 105.1(15)
N(1)-Gd(1)-N(2) 67.03(3) H(6A)-N(6)-H(6B) 103.8(19)
O(3)-Gd(1)-N(3) 122.68(3) N(1)-C(1)-C(2) 112.20(9)
N(5)-Gd(1)-N(3) 93.63(3) N(1)-C(1)-H(1A) 110.5(12)
O(1)-Gd(1)-N(3) 153.84(3) C(2)-C(1)-H(1A) 108.9(12)
O(5)-Gd(1)-N(3) 62.24(3) N(1)-C(1)-H(1B) 107.2(12)
N(6)-Gd(1)-N(3) 127.52(3) C(2)-C(1)-H(1B) 107.5(12)
N(4)-Gd(1)-N(3) 66.49(3) H(1A)-C(1)-H(1B) 110.5(16)
N(1)-Gd(1)-N(3) 102.58(3) O(2)-C(2)-O(1) 125.23(10)
O(5)-Gd(1)-N(3) 62.24(3) O(2)-C(2)-C(1) 117.21(10)
N(6)-Gd(1)-N(3) 127.52(3) O(1)-C(2)-C(1) 117.54(10)
N(4)-Gd(1)-N(3) 66.49(3) N(1)-C(3)-C(4) 111.20(9)
N(1)-Gd(1)-N(3) 102.58(3) N(1)-C(3)-H(3A) 111.6(9)
N(2)-Gd(1)-N(3) 66.61(3) C(4)-C(3)-H(3A) 110.2(9)
C(2)-O(1)-Gd(1) 117.44(7) N(1)-C(3)-H(3B) 108.6(11)
C(2)-O(2)-Li(2)#1 124.50(10) C(4)-C(3)-H(3B) 103.2(11)
C(8)-O(3)-Gd(1) 123.41(7) H(3A)-C(3)-H(3B) 111.8(15)
C(12)-O(5)-Gd(1) 124.45(7) N(2)-C(4)-C(3) 112.23(9)
C(17)-O(7)-Li(2) 149.07(11) N(2)-C(4)-H(4A) 110.0(11)
C(1)-N(1)-C(3) 109.72(9) C(3)-C(4)-H(4A) 108.6(11)
C(1)-N(1)-C(5) 109.02(9) N(2)-C(4)-H(4B) 109.3(10)
C(3)-N(1)-C(5) 109.44(9) C(3)-C(4)-H(4B) 110.0(10)
C(1)-N(1)-Gd(1) 105.20(6) H(4A)-C(4)-H(4B) 106.5(15)
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Table A.2.4. Bond Angles [°] for Asp-AEDO3A-Gd.
C(3)-N(1)-Gd(1) 113.78(7) N(1)-C(5)-C(6) 112.40(10)
N(1)-C(5)-H(5A) 107.6(11) C(13)-C(14)-H(14B) 106.5(9)
C(6)-C(5)-H(5A) 109.6(11) H(14A)-C(14)-H(14B) 108.1(14)
N(1)-C(5)-H(5B) 109.3(10) N(4)-C(15)-C(16) 112.31(9)
C(6)-C(5)-H(5B) 112.3(10) N(4)-C(15)-H(15A) 112.1(10)
H(5A)-C(5)-H(5B) 105.3(15) C(16)-C(15)-H(15A) 110.3(10)
N(4)-C(6)-C(5) 112.16(9) N(4)-C(15)-H(15B) 107.6(11)
N(4)-C(6)-H(6C) 108.6(11) C(16)-C(15)-H(15B) 108.2(12)
C(5)-C(6)-H(6C) 110.2(11) H(15A)-C(15)-H(15B) 106.0(13)
N(4)-C(6)-H(6D) 105.3(12) N(5)-C(16)-C(15) 109.61(9)
C(5)-C(6)-H(6D) 113.0(12) N(5)-C(16)-H(16A) 110.2(10)
H(6C)-C(6)-H(6D) 107.3(15) C(15)-C(16)-H(16A) 110.7(9)
N(2)-C(7)-C(8) 109.25(9) N(5)-C(16)-H(16B) 107.8(12)
N(2)-C(7)-H(7A) 111.4(11) C(15)-C(16)-H(16B) 112.2(12)
C(8)-C(7)-H(7A) 113.1(11) H(16A)-C(16)-H(16B) 106.2(15)
N(2)-C(7)-H(7B) 108.7(12) O(7)-C(17)-N(5) 126.86(11)
C(8)-C(7)-H(7B) 108.1(12) O(7)-C(17)-C(18) 117.83(10)
H(7A)-C(7)-H(7B) 106.1(15) N(5)-C(17)-C(18) 115.31(9)
O(4)-C(8)-O(3) 124.83(11) N(6)-C(18)-C(19) 113.12(9)
O(4)-C(8)-C(7) 118.49(10) N(6)-C(18)-C(17) 109.20(9)
O(3)-C(8)-C(7) 116.68(10) C(19)-C(18)-C(17) 110.50(9)
N(2)-C(9)-C(10) 112.52(9) N(6)-C(18)-H(18) 105.8(8)
N(2)-C(9)-H(9A) 108.6(10) C(19)-C(18)-H(18) 112.2(8)
C(10)-C(9)-H(9A) 108.4(10) C(17)-C(18)-H(18) 105.6(9)
N(2)-C(9)-H(9B) 107.4(11) C(20)-C(19)-C(18) 113.70(9)
C(10)-C(9)-H(9B) 108.2(10) C(20)-C(19)-H(19A) 110.2(11)
H(9A)-C(9)-H(9B) 111.7(14) C(18)-C(19)-H(19A) 109.0(12)
N(3)-C(10)-C(9) 112.30(9) C(20)-C(19)-H(19B) 108.1(11)
N(3)-C(10)-H(10A) 108.0(9) C(18)-C(19)-H(19B) 111.6(11)
C(9)-C(10)-H(10A) 110.3(9) H(19A)-C(19)-H(19B) 103.7(15)
N(3)-C(10)-H(10B) 113.2(15) O(8)-C(20)-O(9) 124.26(11)
C(9)-C(10)-H(10B) 103.7(17) O(8)-C(20)-C(19) 117.05(10)
H(10A)-C(10)-H(10B) 109.4(13) O(9)-C(20)-C(19) 118.66(10)
N(3)-C(11)-C(12) 108.70(9) O(14)-Li-O(11) 107.47(12)
N(3)-C(11)-H(11A) 110.2(12) O(14)-Li-O(13) 107.86(12)
C(12)-C(11)-H(11A) 111.8(11) O(11)-Li-O(13) 120.46(13)
N(3)-C(11)-H(11B) 112.1(11) O(14)-Li-O(12) 104.96(12)
C(12)-C(11)-H(11B) 106.3(11) O(11)-Li-O(12) 115.87(13)
H(11A)-C(11)-H(11B) 107.7(15) O(13)-Li-O(12) 98.99(12)
O(6)-C(12)-O(5) 124.68(11) O(14)-Li-H(13C) 91.1(6)
O(6)-C(12)-C(11) 120.02(10) O(11)-Li-H(13C) 128.5(6)
O(5)-C(12)-C(11) 115.29(10) O(13)-Li-H(13C) 16.8(5)
N(3)-C(13)-C(14) 111.42(10) O(12)-Li-H(13C) 104.1(6)
N(3)-C(13)-H(13A) 110.5(12) O(14)-Li-H(14D) 15.1(8)
C(14)-C(13)-H(13A) 108.5(11) O(11)-Li-H(14D) 117.7(9)
N(3)-C(13)-H(13B) 110.1(11) O(13)-Li-H(14D) 108.2(8)
C(14)-C(13)-H(13B) 107.5(11) O(12)-Li-H(14D) 90.1(8)
H(13A)-C(13)-H(13B) 108.8(17) H(13C)-Li-H(14D) 92.1(10)
N(4)-C(14)-C(13) 111.79(10) Li-O(11)-H(11C) 126.3(17)
N(4)-C(14)-H(14A) 109.9(10) Li-O(11)-H(11D) 123.0(16)
C(13)-C(14)-H(14A) 112.6(10) H(11C)-O(11)-H(11D) 108(2)
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Table A.2.4. Bond Angles [°] for Asp-AEDO3A-Gd.
N(4)-C(14)-H(14B) 107.7(10) Li-O(12)-H(12C) 127.0(15)
Li-O(12)-H(12D) 119.8(16) O(2)#2-Li(2)-O(20) 112.71(11)
H(12C)-O(12)-H(12D) 108(2) O(7)-Li(2)-H(21D) 103.4(5)
Li-O(13)-H(13C) 112.8(16) O(21)-Li(2)-H(21D) 17.9(5)
Li-O(13)-H(13D) 129.0(17) O(2)#2-Li(2)-H(21D) 84.9(5)
H(13C)-O(13)-H(13D) 101(2) O(20)-Li(2)-H(21D) 133.1(6)
Li-O(14)-H(14C) 129.2(15) Li(2)-O(20)-H(20C) 115.2(17)
Li-O(14)-H(14D) 98(3) Li(2)-O(20)-H(20D) 124.4(17)
H(14C)-O(14)-H(14D) 116(3) H(20C)-O(20)-H(20D) 110(2)
O(7)-Li(2)-O(21) 112.57(12) Li(2)-O(21)-H(21C) 119.6(16)
O(7)-Li(2)-O(2)#2 110.53(12) Li(2)-O(21)-H(21D) 109.6(16)
O(21)-Li(2)-O(2)#2 95.64(10) H(21C)-O(21)-H(21D) 106(2)
O(7)-Li(2)-O(20) 109.30(11) H(22A)-O(22)-H(22B) 104(2)
O(21)-Li(2)-O(20) 115.51(12)




Table A.3.5. Anisotropic displacement parameters (Å2x 104 ) for Asp.AEDO3A-Gd. The
anisotropic displacement factor exponent takes the form: The anisotropic displacement
factor exponent takes the form:
-2π2[ h2 a*2 U11 + … + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
Gd(1) 54(1) 50(1) 55(1) 2(1) 6(1) 1(1)
O(1) 97(3) 73(3) 114(3) 15(2) 26(3) -4(2)
O(2) 135(4) 86(3) 125(4) 8(3) 60(3) -5(2)
O(3) 87(3) 108(3) 100(3) 13(3) 15(3) 26(2)
O(4) 111(4) 155(4) 97(4) 35(3) -2(3) 18(3)
O(5) 94(3) 105(3) 88(3) 2(3) 23(3) -17(2)
O(6) 143(4) 135(4) 136(4) 18(3) 0(3) -60(3)
O(7) 184(4) 83(3) 113(4) 3(3) -16(3) 46(3)
O(8) 140(4) 151(4) 97(4) -20(3) 38(3) -26(3)
O(9) 93(3) 173(4) 118(4) -34(3) 3(3) 0(3)
N(1) 91(4) 67(4) 92(4) -5(3) 15(3) 2(3)
N(2) 86(4) 82(4) 82(4) 1(3) 9(3) 4(3)
N(3) 101(4) 81(3) 81(4) -1(3) 9(3) -4(3)
N(4) 98(3) 93(6) 80(3) -11(3) 3(3) 3(3)
N(5) 102(4) 77(4) 71(4) -6(3) -6(3) 12(3)
N(6) 88(4) 78(4) 76(4) 6(3) 3(3) -4(3)
C(1) 118(5) 67(4) 115(5) 7(3) 40(4) -3(3)
C(2) 66(4) 82(4) 105(4) -4(3) 14(3) -11(3)
C(3) 116(5) 80(4) 119(5) -15(3) 30(4) 9(3)
C(4) 115(5) 75(4) 121(5) 8(3) 32(4) 17(3)
C(5) 91(5) 102(5) 122(5) -17(4) 8(4) -15(3)
C(6) 118(4) 91(4) 92(4) -26(3) -6(3) -5(3)
C(7) 90(4) 136(5) 97(4) 15(3) 6(3) 10(3)
C(8) 97(4) 65(4) 104(4) 15(3) 0(3) -1(3)
C(9) 98(4) 104(4) 111(4) 2(3) 35(4) 24(3)
C(10) 83(4) 120(4) 110(4) 8(3) 28(3) 3(3)
C(11) 121(5) 89(4) 101(4) 16(3) 18(4) -21(3)
C(12) 83(4) 91(4) 103(4) 11(3) 15(3) -5(3)
C(13) 118(3) 117(3) 78(3) -5(7) 18(3) 2(7)
C(14) 125(5) 120(4) 74(4) 8(3) 0(3) -6(3)
C(15) 90(4) 101(4) 99(4) -10(3) -13(3) 15(3)
C(16) 109(5) 92(5) 90(4) 6(3) -26(4) 12(3)
C(17) 86(4) 76(4) 73(4) -1(3) 13(3) 5(3)
C(18) 85(4) 75(4) 70(4) -8(3) 4(3) -2(3)
C(19) 97(4) 97(4) 86(4) -14(3) 12(3) 8(3)
C(20) 109(4) 67(4) 88(4) -19(3) 11(3) -1(3)
Li 145(10) 139(10) 135(10) 1(8) 11(8) 7(7)
O(11) 109(4) 167(4) 122(4) -34(3) 7(3) -11(3)
O(12) 150(4) 200(5) 124(4) 3(3) 28(3) 31(3)
O(13) 144(3) 116(5) 147(3) -25(4) 7(3) -1(4)
O(14) 119(4) 179(5) 115(4) -36(3) -3(3) 36(3)
Li(2) 127(10) 98(9) 126(10) 10(7) 19(8) 18(7)
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Table A.3.5. Anisotropic displacement parameters (Å2x 104 ) for Asp.AEDO3A-Gd. The
anisotropic displacement factor exponent takes the form: The anisotropic displacement
factor exponent takes the form:
-2π2[ h2 a*2 U11 + … + 2 h k a* b* U12 ]
U11 U22 U33 U23 U13 U12
O(20) 96(4) 114(4) 130(4) 21(3) 4(3) 6(3)
O(21) 130(4) 152(4) 145(4) -48(3) 41(3) -33(3)
O(22) 112(4) 160(4) 129(4) -29(3) 2(3) 5(3)
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Table A.3.6. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103)
for Asp.AEDO3A-Gd.
x y z Uiso
H(6A) 1510(20) 1723(10) -1920(20) 18(5)
H(6B) 2900(20) 1772(10) -1490(20) 15(4)
H(1A) 4190(20) 4456(10) 260(20) 20(5)
H(1B) 2762(19) 4196(10) -531(19) 6(4)
H(3A) 2071(17) 4857(9) 1713(18) 3(3)
H(3B) 1470(20) 4260(10) 2720(20) 18(5)
H(4A) -385(19) 4597(10) 1101(19) 13(4)
H(4B) 425(18) 4348(9) -82(19) 7(4)
H(5A) 4320(20) 4294(10) 2900(20) 18(5)
H(5B) 4997(19) 3626(9) 2233(19) 6(4)
H(6C) 4510(20) 3357(10) 4650(20) 15(4)
H(6D) 2860(20) 3548(10) 4292(19) 13(4)
H(7A) -2110(20) 3727(10) -490(20) 16(4)
H(7B) -1830(20) 2891(10) -230(20) 21(5)
H(9A) -2080(18) 3689(9) 2103(18) 8(4)
H(9B) -515(19) 3726(10) 3070(20) 7(4)
H(10A) -1854(17) 2682(8) 3733(18) 10(4)
H(10B) -1959(16) 2492(16) 2078(16) 15(3)
H(11A) -940(20) 1377(10) 3650(20) 14(4)
H(11B) 526(18) 1224(9) 3193(18) 6(4)
H(13A) 360(20) 2262(9) 5240(20) 21(5)
H(13B) 796(19) 2979(10) 4620(20) 13(4)
H(14A) 2934(16) 2376(10) 5539(17) 10(4)
H(14B) 2479(17) 1737(9) 4524(18) 5(4)
H(15A) 5295(18) 2158(9) 4230(19) 10(4)
H(15B) 5253(15) 2430(13) 2657(16) 10(4)
H(16A) 5381(19) 1138(9) 2570(20) 7(4)
H(16B) 3950(20) 1106(10) 3470(20) 19(5)
H(18) 1322(17) 700(8) -577(17) 1(3)
H(19A) 3146(19) -81(10) -1540(20) 15(4)
H(19B) 4040(20) 543(10) -2000(20) 14(4)
H(11C) 6230(20) 625(11) 5350(20) 20(5)
H(11D) 5100(20) 676(11) 5860(20) 24(5)
H(12C) 5600(20) 1908(13) 9560(20) 32(6)
H(12D) 6400(20) 1302(12) 9790(30) 31(6)
H(13C) 7120(20) 2758(11) 6700(20) 28(6)
H(13D) 5950(20) 2835(11) 7040(20) 29(6)
H(14C) 9300(20) 1061(11) 7290(20) 15(4)
H(14D) 8890(30) 1405(16) 8140(30) 53(10)
H(20C) 7200(20) 226(13) 2780(30) 34(6)
H(20D) 7340(20) -198(13) 3830(30) 29(6)
H(21C) 3120(20) -365(14) 4370(20) 30(6)
H(21D) 2810(20) -880(12) 3520(20) 21(5)
H(22A) -220(20) -362(12) -5060(30) 28(6)
H(22B) -160(20) -846(12) -5880(20) 29(5)
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Table A.1.7. Hydrogen bonds for Asp-AEDO3A-Gd [Å and °].
D-H…A d(D-H) d(H…A) d(D…A) <(DHA)
N(6)-H(6A)...O(14)#3 0.882(19) 2.499(19) 3.1831(15) 134.9(16)
N(6)-H(6B)...O(1) 0.746(18) 2.489(19) 2.8773(13) 114.3(17)
O(11)-H(11C)...O(20) 0.70(2) 2.30(2) 2.9937(14) 167(2)
O(11)-H(11D)...O(8)#4 0.74(2) 2.00(2) 2.7421(14) 177(2)
O(12)-H(12C)...O(1)#4 0.85(2) 2.12(2) 2.9396(13) 162(2)
O(12)-H(12D)...O(6)#5 0.79(2) 2.15(2) 2.9033(14) 159(2)
O(13)-H(13C)...O(4)#5 0.73(2) 2.16(2) 2.8701(15) 167(2)
O(13)-H(13D)...O(2)#4 0.75(2) 2.06(2) 2.7890(15) 168(2)
O(14)-H(14C)...O(9)#5 0.75(2) 2.04(2) 2.7783(14) 171.9(19)
O(14)-H(14D)...O(5)#5 0.54(3) 2.25(3) 2.7823(15) 165(4)
O(20)-H(20C)...O(6)#6 0.76(2) 2.07(2) 2.8271(13) 175(2)
O(20)-H(20D)...O(22)#5 0.76(2) 2.01(2) 2.7211(13) 158(2)
O(21)-H(21C)...O(8)#4 0.81(2) 1.89(2) 2.6771(13) 163(2)
O(21)-H(21D)...O(4)#7 0.75(2) 2.09(2) 2.8219(14) 169(2)
O(22)-H(22A)...O(9) 0.70(2) 2.11(2) 2.7816(13) 161(2)
O(22)-H(22B)...O(4)#8 0.79(2) 2.05(2) 2.8324(14) 172(2)
Symmetry transformations used to generate equivalent atoms:
#1 -x+1,y+1/2,-z
#2 -x+1,y-1/2,-z
#3 x-1,y,z-1
#4 x,y,z+1
#5 x+1,y,z+1
#6 x+1,y,z
#7 -x,y-1/2,-z
#8 -x,y-1/2,-z-1
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